<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">EMBO J</span><span class="iso-abbrev" title="iso-abbrev">EMBO J</span><span class="doi" title="doi">10.1002/(ISSN)1460-2075</span><span class="publisher-id" title="publisher-id">EMBJ</span><span class="hwp" title="hwp">embojnl</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">The EMBO Journal</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0261-4189</span><span class="issn-epub" tagx="issn" title="issn-epub">1460-2075</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">John Wiley and Sons Inc.</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Hoboken</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7537045">7537045</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/32944968">32944968</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.15252/embj.2020106057">10.15252/embj.2020106057</a></span><span class="publisher-id" title="publisher-id">EMBJ2020106057</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span>: <span class="subject" title="subject">Articles</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Cholesterol 25â€�Hydroxylase inhibits <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 and other coronaviruses by depleting membrane cholesterol</div> <div class="alt-title" title="alt-title">
Shaobo Wang <i>etÂ al</i></div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Shaobo</span></span><a href="#embj2020106057-aff-0001"><sup>1</sup></a><a href="#embj2020106057-note-1001"><sup>â€ </sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Wanyu</span></span><a href="#embj2020106057-aff-0001"><sup>1</sup></a><a href="#embj2020106057-aff-0002"><sup>2</sup></a><a href="#embj2020106057-note-1001"><sup>â€ </sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hui</span><span class="given-names" tagx="given-names" title="given-names">Hui</span></span><a href="#embj2020106057-aff-0001"><sup>1</sup></a><a href="#embj2020106057-aff-0002"><sup>2</sup></a><a href="#embj2020106057-aff-0003"><sup>3</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tiwari</span><span class="given-names" tagx="given-names" title="given-names">Shashi Kant</span></span><a href="#embj2020106057-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Qiong</span></span><a href="#embj2020106057-aff-0001"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Croker</span><span class="given-names" tagx="given-names" title="given-names">Ben A</span></span><a href="#embj2020106057-aff-0004"><sup>4</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rawlings</span><span class="given-names" tagx="given-names" title="given-names">Stephen</span></span><a href="#embj2020106057-aff-0005"><sup>5</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">Davey</span></span><a href="#embj2020106057-aff-0005"><sup>5</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carlin</span><span class="given-names" tagx="given-names" title="given-names">Aaron F</span></span><a href="#embj2020106057-aff-0005"><sup>5</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rana</span><span class="given-names" tagx="given-names" title="given-names">Tariq M</span></span><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-9558-5766</span><a href="#embj2020106057-aff-0001"><sup>1</sup></a><span class="address" title="address"><span class="email" tagx="email" title="email">trana@ucsd.edu</span></span></span></div><span class="citation_author_institution" id="embj2020106057-aff-0001">[1], <span class="named-content" title="named-content">Division of Genetics</span><span class="named-content" title="named-content">Department of Pediatrics</span><span class="named-content" title="named-content">Institute for Genomic Medicine</span><span class="named-content" title="named-content">Program in Immunology</span><span class="institution" title="institution">University of California San Diego</span><span class="city" tagx="city" title="city">La Jolla</span><span class="named-content" title="named-content">CA</span><span class="country" tagx="country" title="country">USA</span></span><span class="citation_author_institution" id="embj2020106057-aff-0002">[2], <span class="named-content" title="named-content">Department of Biology</span><span class="institution" title="institution">University of California San Diego</span><span class="city" tagx="city" title="city">La Jolla</span><span class="named-content" title="named-content">CA</span><span class="country" tagx="country" title="country">USA</span></span><span class="citation_author_institution" id="embj2020106057-aff-0003">[3], <span class="named-content" title="named-content">Bioinformatics Program</span><span class="institution" title="institution">University of California San Diego</span><span class="city" tagx="city" title="city">La Jolla</span><span class="named-content" title="named-content">CA</span><span class="country" tagx="country" title="country">USA</span></span><span class="citation_author_institution" id="embj2020106057-aff-0004">[4], <span class="named-content" title="named-content">Division of Allergy, Immunology, and Rheumatology</span><span class="named-content" title="named-content">Department of Pediatrics</span><span class="institution" title="institution">University of California San Diego</span><span class="city" tagx="city" title="city">La Jolla</span><span class="named-content" title="named-content">CA</span><span class="country" tagx="country" title="country">USA</span></span><span class="citation_author_institution" id="embj2020106057-aff-0005">[5], <span class="named-content" title="named-content">Division of Infectious Diseases and Global Public Health</span><span class="named-content" title="named-content">Department of Medicine</span><span class="institution" title="institution">University of California San Diego</span><span class="city" tagx="city" title="city">La Jolla</span><span class="named-content" title="named-content">CA</span><span class="country" tagx="country" title="country">USA</span></span><div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">*</span>Corresponding author (lead contact). Tel: +1 858 246 1100; Eâ€�mail: <span class="email" tagx="email" title="email">trana@ucsd.edu</span></div> <div class="fn-type-equal" title="equal"><span class="label" tagx="label" title="label">â€ </span><p>These authors contributed equally to this work</p> </div> </div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-10-10</span></span><span class="elocation-id" tagx="elocation-id" title="elocation-id">e106057</span><span class="history" title="history"><span class="received" title="received">received: 2020-6-25</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-9-09</span><span class="accepted" title="accepted">accepted: 2020-9-14</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , </span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="file:EMBJ-9999-e106057.pdf" title="self-uri">file:EMBJ-9999-e106057.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Coronavirus disease 2019 (<span class="styled-content" tagx="styled-content" title="styled-content">COVID</span>â€�19) is caused by <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 and has spread across the globe. <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 is a highly infectious virus with no vaccine or antiviral therapy available to control the pandemic; therefore, it is crucial to understand the mechanisms of viral pathogenesis and the host immune responses to <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2. <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 is a new member of the betacoronavirus genus like other closely related viruses including <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoV and Middle East respiratory syndrome coronavirus (<span class="styled-content" tagx="styled-content" title="styled-content">MERS</span>â€�CoV). Both <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoV and <span class="styled-content" tagx="styled-content" title="styled-content">MERS</span>â€�CoV have caused serious outbreaks and epidemics in the past eighteen years. Here, we report that one of the interferonâ€�stimulated genes (<span class="styled-content" tagx="styled-content" title="styled-content">ISG</span>s), cholesterol 25â€�hydroxylase (<i><span class="styled-content" tagx="styled-content" title="styled-content">CH</span>25H</i>), is induced by <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 infection <i>inÂ vitro</i> and in <span class="styled-content" tagx="styled-content" title="styled-content">COVID</span>â€�19â€�infected patients. <span class="styled-content" tagx="styled-content" title="styled-content">CH</span>25H converts cholesterol to 25â€�hydrocholesterol (25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span>) and 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> shows broad antiâ€�coronavirus activity by blocking membrane fusion. Furthermore, 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> inhibits <span class="styled-content" tagx="styled-content" title="styled-content">USA</span>â€�<span class="styled-content" tagx="styled-content" title="styled-content">WA</span>1/2020 <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 infection in lung epithelial cells and viral entry in human lung organoids. Mechanistically, 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> inhibits viral membrane fusion by activating the <span class="styled-content" tagx="styled-content" title="styled-content">ER</span>â€�localized acylâ€�CoA:cholesterol acyltransferase (<span class="styled-content" tagx="styled-content" title="styled-content">ACAT</span>) which leads to the depletion of accessible cholesterol from the plasma membrane. Altogether, our results shed light on a potentially broad antiviral mechanism by 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> through depleting accessible cholesterol on the plasma membrane to suppress virusâ€"cell fusion. Since 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> is a natural product with no known toxicity at effective concentrations, it provides a potential therapeutic candidate for <span class="styled-content" tagx="styled-content" title="styled-content">COVID</span>â€�19 and emerging viral diseases in the future.</p> </div> <div class="abstract" title="abstract"> <p>Interferonâ€�induced cholesterol hydroxylation, and subsequent activation of the <span class="styled-content" tagx="styled-content" title="styled-content">ER</span>â€�localized <span class="styled-content" tagx="styled-content" title="styled-content">ACAT</span> enzyme that depletes accessible cholesterol, represents a new host defence mechanism restricting membrane fusion and entry of severely pathogenic coronaviruses. </p><div class="boxed-text" tagx="boxed-text" title="boxed-text"> <div class="graphic" position="anchor" id="nlm-graphic-3" orientation="portrait" /> </div> <p /> </div> <div class="kwd-group"> <div class="kwd" title="kwd">
cholesterol 25â€�hydroxylase</div> <div class="kwd" title="kwd"><span class="styled-content" tagx="styled-content" title="styled-content">COVID</span>â€�19 treatment</div> <div class="kwd" title="kwd">
innate immunity</div> <div class="kwd" title="kwd">
restriction factor of coronaviruses</div> <div class="kwd" title="kwd">
viral fusion</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Subject Categories</div> <div class="kwd" title="kwd">
Membrane &amp;amp; Intracellular Transport</div> <div class="kwd" title="kwd">
Microbiology, Virology &amp;amp; Host Pathogen Interaction</div> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source">
HHS|NIH|National Cancer Institute (NCI)</div><span class="award-id" tagx="award-id" title="award-id">CA177322</span></div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution" title="institution">HHS|NIH|National Institute on Drug Abuse (NIDA) </span><span class="institution-id" title="institution-id">10.13039/100000026</span></div> </div><span class="award-id" tagx="award-id" title="award-id">DA039562</span><span class="award-id" tagx="award-id" title="award-id">DA049524</span></div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source">
HHS|NIH|National Institute of Allergy and Infectious Diseases (NIAID)</div><span class="award-id" tagx="award-id" title="award-id">AI125103</span></div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="source-schema-version-number" value="2.0" /> <meta name="edited-state" value="corrected-proof" /> <meta name="details-of-publishers-convertor" value="Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.2 mode:remove_FC converted:06.10.2020" /> </div> </div> <p content-type="self-citation"><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="source" tagx="source" title="source">The EMBO Journal</span> (<span class="year" tagx="year" title="year">2020</span>) <span class="elocation-id" tagx="elocation-id" title="elocation-id">e106057</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32944968">32944968</a></span></span></p> </div> <div class="body" title="body"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Coronavirus disease 2019 (COVIDâ€�19) is a transmissible respiratory disease caused by a novel severe acute respiratory syndrome coronavirus SARSâ€�CoVâ€�2. Since its emergence in December 2019, COVIDâ€�19 has rapidly spread worldwide spanning 216 countries (Sun <i>etÂ al</i>, <a href="#embj2020106057-bib-0029">2020</a>). As of September 7<sup>th</sup>, there are 27,236,916 confirmed cases and 891,031 deaths (WHO COVID Pandemic). There is currently no approved vaccine for this disease, and there is an urgent need for developing therapeutic strategies. The etiologic agent of COVIDâ€�19, SARSâ€�CoVâ€�2, is an enveloped positiveâ€�sense singleâ€�stranded RNA virus. SARSâ€�CoVâ€�2 is a new member of the betacoronavirus genus and other closely related viruses include SARSâ€�CoV and Middle East respiratory syndrome coronavirus (MERSâ€�CoV). Both SARSâ€�CoV and MERSâ€�CoV caused serious outbreaks and epidemics in the past eighteen years (Cui <i>etÂ al</i>, <a href="#embj2020106057-bib-0006">2019</a>). SARSâ€�CoVâ€�2 uses angiotensinâ€�converting enzyme 2 (ACE2) as a host cell receptor, and transmembrane protease, serine 2 (TMPRSS2) to cleave its spike (S) protein for entry into the cell (Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0015">2020b</a>).</p> <p>Interferons (IFNs) are induced upon coronavirus infections (Park &amp;amp; Iwasaki, <a href="#embj2020106057-bib-0025">2020</a>). IFNs are signaling molecules of the innate immune system that confer a first line of antiviral defense (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>). Upon sensing of molecular patterns associated with viral infections, IFN pathways become activated, engendering further activation of hundreds of interferonâ€�stimulated genes (ISGs) that counteract many steps in the virus life cycle (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>). Human type I IFNs including IFNâ€�Î± and IFNâ€�Î² function through the ubiquitously expressed type I interferon receptor (IFNAR), while type III IFNs, IFNâ€�Î», bind to the epitheliaâ€�restricted type III interferon receptor (IFNLR; de Weerd &amp;amp; Nguyen, <a href="#embj2020106057-bib-0031">2012</a>). <i>In vitro</i> and clinical studies have shown that SARSâ€�CoVâ€�2 is sensitive to type I IFNs and that type I IFN treatment could be a promising therapeutic strategy for COVIDâ€�19 (Mantlo <i>etÂ al</i>, <a href="#embj2020106057-bib-0021">2020</a>; preprint: Meng <i>etÂ al</i>, <a href="#embj2020106057-bib-0022">2020</a>; preprint: Zhou <i>etÂ al</i>, <a href="#embj2020106057-bib-0037">2020</a>).</p> <p>Cholesterolâ€�25â€�hydroxylase (CH25H) is one of the ISGs (Schneider <i>etÂ al</i>, <a href="#embj2020106057-bib-0026">2014</a>), which encodes an enzyme that synthesizes the oxysterol 25â€�hydroxycholesterol (25HC) from cholesterol (Lund <i>etÂ al</i>, <a href="#embj2020106057-bib-0020">1998</a>). 25HC has been shown to have broad antiviral activity by inhibiting the host cell entry of human immunodeficiency virus (HIV), vesicular stomatitis virus (VSV), Zika virus (ZIKV), Ebola virus (EBOV), Nipah virus (NiV), Russian springâ€�summer encephalitis virus (RSSEV), porcine viruses (PEDV, PEGV, porcine intestine coronavirus), reovirus, and norovirus (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>; Li <i>etÂ al</i>, <a href="#embj2020106057-bib-0017">2017</a>). For ZIKV, treatment with 25HC protected mice and rhesus monkeys from ZIKV infection (Li <i>etÂ al</i>, <a href="#embj2020106057-bib-0017">2017</a>). For the mechanism of entry inhibition, there is evidence that 25HC could modify plasma membrane composition (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>). However, the pathways mediating 25HCâ€�induced modification of the plasma membrane that inhibits virus entry are unclear.</p> <p>In this paper, we report the antiviral activity of CH25H against SARSâ€�CoVâ€�2 entry into human lung epithelial cells and show that 25HC broadly inhibits infection by human coronaviruses including SARSâ€�CoV and MERSâ€�CoV. By addressing the mechanism of 25HC function, we provide evidence that 25HC induced depletion of cholesterol on the plasma membrane through activating acylâ€�CoA:cholesterol acyltransferase (ACAT), thereby restricting virus fusion at the cell surface. We further confirmed the inhibitory effect of 25HC on authentic SARSâ€�CoVâ€�2 infection of lung epithelial cells and viral entry in human lung organoids. These results shed light on one of the mechanisms by which interferon signaling and type I interferon therapy in COVIDâ€�19â€�infected patients counteract SARSâ€�CoVâ€�2 at the molecular level, with implications for cholesterol homeostasis in broadâ€�spectrum antiviral immunity.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <div class="ch25hisinducedbysarsâ€�covâ€�2infectionandrestrictsviralentry" title="sec"> <div class="title" tagx="title" title="title"><i>CH25H</i> is induced by SARSâ€�CoVâ€�2 infection and restricts viral entry</div> <p>Since <i>CH25H</i> is an ISG and broadly inhibits viruses (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>), we sought to investigate the role of CH25H during SARSâ€�CoVâ€�2 infection. We analyzed RNAâ€�seq data of SARSâ€�CoVâ€�2 infection in two lung epithelial cell lines, Caluâ€�3 and A549â€�ACE2 (Blancoâ€�Melo <i>etÂ al</i>, <a href="#embj2020106057-bib-0003">2020</a>), for upâ€�regulated ISGs. SARSâ€�CoVâ€�2 infection dramatically induced type I and III interferons, including IFNB1 and IFNL1, but not type II interferon (FigÂ <a href="#embj2020106057-fig-0001">1</a>A). Multiple wellâ€�known ISGs were simultaneously elevated, such as <i>ISG15</i>,<i> OASL</i>,<i> IFITMs,</i> and the <i>IFITs</i> (FigÂ <a href="#embj2020106057-fig-0001">1</a>A). Importantly, <i>CH25H</i> expression was significantly upâ€�regulated in both cell lines (FigÂ <a href="#embj2020106057-fig-0001">1</a>A). Similar results were obtained from infections by human parainfluenza virus type 3 (HPIV3) and respiratory syncytial virus (RSV) but not influenza A virus, whose NS1 protein could completely block interferon pathways (FigÂ <a href="#embj2020106057-fig-0001">1</a>A). In corroboration with these cell lineâ€�based data, scRNAâ€�seq analysis of bronchoalveolar lavage fluids from healthy donors and COVIDâ€�19â€�infected patients revealed an upâ€�regulation of <i>CH25H</i> in macrophages and epithelial cells in COVIDâ€�19â€�infected patients compared to healthy donors (FigsÂ <a href="#embj2020106057-fig-0001">1</a>B and <a href="#embj2020106057-fig-0001ev">EV1</a>A; Liao <i>etÂ al</i>, <a href="#embj2020106057-bib-0018">2020</a>). Another RNAâ€�seq analysis also showed robust induction of <i>CH25H</i> in PBMCs from COVIDâ€�19â€�infected patients relative to healthy donors (FigÂ <a href="#embj2020106057-fig-0001ev">EV1</a>B; preprint: Daamen <i>etÂ al</i>, <a href="#embj2020106057-bib-0007">2020</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1</span></a></div>   <div class="title" tagx="title" title="title"><i>Cholesterol 25â€�hydroxylase (<span class="styled-content" tagx="styled-content" title="styled-content">CH</span>25H)</i> is induced by <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 and restricts viral infection</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A</span><p>IFNs and ISGs were induced by SARSâ€�CoV-2 infection in lung epithelial cell lines: Caluâ€�3 and A549â€�ACE2 were infected with SARSâ€�CoV-2 at MOIÂ =Â 2 for 24Â h; A549 was challenged with IAV at MOIÂ =Â 5 for 9Â h; A549 was infected with HPIV3 and RSV at MOIÂ =Â 2 for 24Â h (Blancoâ€�Melo <i>etÂ al</i>, <a href="#embj2020106057-bib-0003">2020</a>). Color key represents log2(fold change) relative to uninfected control cells. <i>CH25H</i> was highlighted by red asterisk.</p> </li> <li><span class="label" tagx="label" title="label">B</span><p>Expression of <i>CH25H</i> in heathy donors and COVIDâ€�19-infected patients. The box plot shows the expression of <i>CH25H</i> in macrophages of bronchoalveolar lavage fluids from four healthy donors, three moderate COVIDâ€�19-infected patients and six severe COVIDâ€�19-infected patients by scRNAâ€�seq analysis (Liao <i>etÂ al</i>, <a href="#embj2020106057-bib-0018">2020</a>). *<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN">
tâ€�test.</div></div></p> </li> <li><span class="label" tagx="label" title="label">Câ€"E</span><p>Characterization of SARSâ€�CoV-2 pseudovirus. (C) SARSâ€�CoV-2, SARSâ€�CoV, and VSV pseudovirus (VSVâ€�G) were concentrated by ultracentrifuge. Incorporation of spike protein on viral membrane was analyzed by Western blot using an antibody recognizing S2 subunit of SARSâ€�CoV and SARSâ€�CoV-2. VSV Matrix protein served as a loading control for viral particles. Black arrows indicate full length S and cleaved spike (S2 subunit), respectively. (D) SARSâ€�CoV-2 pseudovirus infection in Caluâ€�3 cells with or without treatment of coronavirus fusion peptide EK1. Luciferase activity was measured to quantify the infection. (E) SARSâ€�CoV-2 pseudovirus infection in Caluâ€�3 cells transduced with nonâ€�targeting control or ACE2â€�specific sgRNA. Luciferase activity was measured to quantify the infection. MeanÂ Â±Â SD of <i>n</i>Â =Â 3. ***<i>PÂ <div class="â_UNKNOWN" /></i>0.001, ****<i>PÂ <div class="â_UNKNOWN" /></i>0.0001, by Student's <i>t</i>â€�test.</p> </li> <li><span class="label" tagx="label" title="label">F, G</span><p>Overexpression of <i>CH25H</i> restricts SARSâ€�CoV-2 entry. Caluâ€�3 cells transduced with lentivirus overexpressing <i>CH25H</i> or empty vector were infected with SARSâ€�CoV-2 pseudovirus encoding Fluc or EGFP and pseudovirus infection was quantified by luciferase assay (F) or visualized by fluorescence microscopy (G). Scale bar, 100Â Î¼m. MeanÂ Â±Â SD of <i>n</i>Â =Â 3. ****<i>P</i>Â <div class="â_UNKNOWN">
tâ€�test.</div></p> </li> </ul> <p /> <p><span class="named-content" title="named-content">Source data are available online for this figure.</span></p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure EV1</span></a></div>   <div class="title" tagx="title" title="title">
(Related to FigÂ <a href="#embj2020106057-fig-0001">1</a>). <i><span class="styled-content" tagx="styled-content" title="styled-content">CH</span>25H</i> induction in <span class="styled-content" tagx="styled-content" title="styled-content">COVID</span>â€�19â€�infected patient and characterization of <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 pseudovirus</div> <p> </p><ul> <li> <p>The box plot shows the expression of <i>CH25H</i> in epithelia of bronchoalveolar lavage fluids from four healthy donors, three moderate COVIDâ€�19-infected patients and six severe COVIDâ€�19-infected patients by scRNAâ€�seq analysis (Liao <i>etÂ al</i>, <a href="#embj2020106057-bib-0018">2020</a>). *<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN">
tâ€�test</div></div></p> </li> <li> <p>RNAâ€�seq analysis showed robust induction of <i>CH25H</i> in PBMCs from COVIDâ€�19-infected patients relative to healthy donors (Blancoâ€�Melo <i>etÂ al</i>, <a href="#embj2020106057-bib-0003">2020</a>).</p> </li> <li> <p>Overexpression of SARSâ€�CoV-2 and SARSâ€�CoV spike protein in 293FT cells. The plasmids encoding SARSâ€�CoV-2 or SARSâ€�CoV spike protein was transfected in 293FT cells and expression of spike protein was analyzed by Western blotting using an antibody recognizing S2 subunit of SARSâ€�CoV and SARSâ€�CoV-2. Black arrows indicate full length spike protein and cleaved spike (S2 subunit), respectively.</p> </li> <li> <p>TMPRSS2 inhibitors, camostat and nafamostat, blocked entry of SARSâ€�CoV-2 but not VSV. Caluâ€�3 cells were treated with 10Â Î¼M camostat, 10Â Î¼M nafamostat or DMSO for 1Â h. Then, the cells were infected with SARSâ€�CoV-2 or VSV pseudovirus with EGFP for 1Â h. EGFP signals were captured by fluorescence microscope 24Â h postâ€�infection. Scale bar, 100Â Î¼M.</p> </li> <li> <p>Knockout efficiency of ACE2 in Caluâ€�3 cells. Caluâ€�3 cells were transduced with nonâ€�targeting control or ACE2â€�specific sgRNA. ACE2 expression was analyzed by Western blotting. Black arrow indicates the band for ACE2.</p> </li> </ul> <p /> <p><span class="named-content" title="named-content">Source data are available online for this figure.</span></p>   </div> <p>Considering that CH25H has been demonstrated to restrict entry of several viruses including HIV, HSV, and a positive strand virus ZIKV (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>; Li <i>etÂ al</i>, <a href="#embj2020106057-bib-0017">2017</a>), we constructed SARSâ€�CoVâ€�2 pseudovirus based on VSV to investigate the viral entry process. We first checked the expression SARSâ€�CoVâ€�2 spike during packaging of VSV pseudovirus bearing spike (FigÂ <a href="#embj2020106057-fig-0001ev">EV1</a>C). Immunoblotting revealed two forms of the spike protein: full length S and the S2 subunit (FigÂ <a href="#embj2020106057-fig-0001">1</a>C). Consistent with previous findings, S2 is highly abundant in SARSâ€�CoVâ€�2 (FigÂ <a href="#embj2020106057-fig-0001">1</a>C), because of a furin cleavage motif near the boundary of S1/S2 that promotes proteolytic processing (Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0014">2020a</a>). Similar bands were observed for VSV particles bearing the SARSâ€�CoV spike protein (FigÂ <a href="#embj2020106057-fig-0001">1</a>C), though the S2 band was less prominent due to the lack of any furin cleavage site (Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0014">2020a</a>). In addition, utilizing a fusion inhibition peptide EK1 targeting the HR1 domain of the spike protein, we confirmed that pseudovirus entry is mediated by the spike protein because EK1 treatment potently inhibited viral infection in Caluâ€�3 cells (FigÂ <a href="#embj2020106057-fig-0001">1</a>D). To further authenticate our pseudovirus, we tested infection of the human lung epithelial cell line Caluâ€�3 treated with TMPRSS2 inhibitors camostat and nafamostat (FigÂ <a href="#embj2020106057-fig-0001ev">EV1</a>D). SARSâ€�CoVâ€�2 pseudovirus infection was abolished in cells treated with inhibitors as compared with vehicle control (FigÂ <a href="#embj2020106057-fig-0001ev">EV1</a>D). Furthermore, infection was significantly repressed in ACE2 knockout Caluâ€�3 cells (FigsÂ <a href="#embj2020106057-fig-0001">1</a>E and <a href="#embj2020106057-fig-0001ev">EV1</a>E). Altogether, our results demonstrate that the entry of SARSâ€�CoVâ€�2 pseudovirus is mediated by spike and primed by cellular ACE2 and TMPRSS2, providing the validation of our pseudovirus system to authentically mimic SARSâ€�CoVâ€�2 entry.</p> <p>Next, using the SARSâ€�CoVâ€�2 pseudovirus, we aimed to functionally validate the correlation between the upâ€�regulation of <i>CH25H</i> and SARSâ€�CoVâ€�2 infection. We overexpressed <i>CH25H</i> in Caluâ€�3 cells prior to SARSâ€�CoVâ€�2 pseudovirus challenge (FigÂ <a href="#embj2020106057-fig-0001">1</a>F and G). Our results showed that overexpression of <i>CH25H</i> significantly suppressed SARSâ€�CoVâ€�2 pseudovirus infection (FigÂ <a href="#embj2020106057-fig-0001">1</a>F and G). Taken together, these data suggest that the upâ€�regulation of <i>CH25H</i> upon SARSâ€�CoVâ€�2 infection <i>inÂ vitro</i> and <i>inÂ vivo</i> restricts SARSâ€�CoVâ€�2 infection.</p> </div> <div class="25â€�hydroxycholesterol(25hc)broadlyinhibitsviralentryofhumancoronavirusesbyblockingmembranefusion" title="sec"> <div class="title" tagx="title" title="title">
25â€�Hydroxycholesterol (25HC) broadly inhibits viral entry of human coronaviruses by blocking membrane fusion</div> <p>To determine whether <i>CH25H</i> inhibits SARSâ€�CoVâ€�2 infection by 25HC production, Caluâ€�3 cells were treated with a concentration gradient of 25HC, followed by infection with SARSâ€�CoVâ€�2 pseudovirus encoding either Firefly luciferase or EGFP (FigÂ <a href="#embj2020106057-fig-0002">2</a>A and B). Pseudovirus entry was potently inhibited by 25HC in a doseâ€�dependent manner, with a halfâ€�maximal inhibitory concentration (IC<sub>50</sub>) of 550Â nM (FigÂ <a href="#embj2020106057-fig-0002">2</a>A). This inhibitory effect was confirmed by diminished numbers of EGFPâ€�positive cells, pretreated with 25HC as compared with ethanol (EtOH) vehicle, and challenged with EGFPâ€�expressing pseudovirus (FigÂ <a href="#embj2020106057-fig-0002">2</a>B). In light of the findings of SARSâ€�CoVâ€�2 infection in the gastrointestinal tract (Zang <i>etÂ al</i>, <a href="#embj2020106057-bib-0035">2020</a>), we asked whether the viral inhibition by 25HC was specific to lung epithelial cells or it was a broad cell type mechanism for viral entry. To address this question, we analyzed pseudovirus entry into Cacoâ€�2 cells, a colorectal epithelial cell line, which also expresses ACE2 and TMPRSS2 as found in Caluâ€�3 cells. Using FLucâ€�expressing pseudovirus, we observed a doseâ€�dependent restriction of entry by 25HC (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>A). All concentrations of 25HC used in these experiments are nonâ€�cytotoxic to both Cacoâ€�2 (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>B) and Caluâ€�3 cells (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>C), and further 25HC does not exert significant background change in viral gene expression (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>D). In contrast, 7Î±â€�HC, which is structurally similar to 25HC, did not show any antiviral activity (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>E). Thus, our results show that 25HC limits SARSâ€�CoVâ€�2 infection in both lung and intestinal epithelial cells.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2</span></a></div>   <div class="title" tagx="title" title="title">
25â€�Hydrocholesterol (25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span>) blocks entry of human coronaviruses and spikeâ€�mediated membrane fusion</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">Aâ€"D</span><p>25HC inhibits entry of SARSâ€�CoV-2 pseudovirus (A and B), SARSâ€�CoV pseudovirus (C), and MERSâ€�CoV pseudovirus (D). Caluâ€�3 cells were treated with EtOH or indicated concentrations of 25HC for 16Â h. Cells were then challenged with FLucâ€�expressing pseudovirus (A, C and D) and EGFPâ€�expressing pseudovirus (B, C and D) at MOIÂ =Â 0.2, with EtOH or 25HC. After 2Â h of infection, virus was removed and pseudovirus infection was quantified by luciferase assay at 24Â h postâ€�infection (A, C and D) or visualized by fluorescence microscopy (B, C and D). IC<sub>50</sub> was calculated by GraphPad using nonâ€�linear regression analysis. Statistical analyses were conducted by Student's <i>t</i>â€�test. Scale bar, 100Â Î¼m. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 4. *<i>PÂ <div class="â_UNKNOWN" /></i>0.05, **<i>PÂ <div class="â_UNKNOWN" /></i>0.01, ***<i>PÂ <div class="â_UNKNOWN" /></i>0.001, ****<i>PÂ <div class="â_UNKNOWN" /></i>0.0001.</p> </li> <li><span class="label" tagx="label" title="label">E</span><p>25HC does not inhibit SARSâ€�CoV-2 pseudovirus receptor binding. Caluâ€�3 cells were treated with EtOH or 25HC (2.5 or 5Â Î¼M) for 24Â h prior to challenge by SARSâ€�CoV-2 pseudovirus at 4Â°C for 1Â h. Total cellular RNA was extracted and quantified for VSVâ€�L by qPCR. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 4.</p> </li> <li><span class="label" tagx="label" title="label">F, G</span><p>25HC inhibits membrane fusion mediated by SARSâ€�CoV-2 S (F), SARSâ€�CoV S (G, left), and MERSâ€�CoV S (G, right). 293FT or Vero cells were treated with EtOH or 25HC (5Â Î¼M) for 16Â h prior to transfection with pLVX plasmids encoding SARSâ€�CoV-2 S (F), SARSâ€�CoV S (G, left), and MERSâ€�CoV S (G, right) in the absence of EtOH or 25HC. At 24Â h postâ€�transfection, syncytium formation was visualized by fluorescence microscopy. Scale bar, 50Â Î¼m. White arrows indicate syncytia. Quantification of membrane fusion was performed by calculating the percentages of nuclei involved in syncytia formation from all nuclei in GFPâ€�positive cells. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. **<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN">
tâ€�test.</div></div></p> </li> </ul> <p />   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure EV2</span></a></div>   <div class="title" tagx="title" title="title">
(Related to FigÂ <a href="#embj2020106057-fig-0002">2</a>). 25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span> is not cytotoxic to Cacoâ€�2 and Caluâ€�3 cells and inhibits coronavirus Sâ€�induced membrane fusion</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A</span><p>25HC inhibits SARSâ€�CoV-2 pseudovirus entry into Cacoâ€�2 cells. Following a 16â€�h incubation with EtOH or indicated concentrations of 25HC, cells were challenged with SARSâ€�CoV-2 pseudovirus encoding FLuc. After virus removal at 2Â h, cells were lysed and luciferase activity was measured after 24Â h. Statistical analyses were conducted by Student's <i>t</i>â€�test. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. *<i>PÂ <div class="â_UNKNOWN" /></i>0.05.</p> </li> <li><span class="label" tagx="label" title="label">B, C</span><p>25HC is not cytotoxic to Cacoâ€�2 (B) or Caluâ€�3 cells (C). Cell were treated with EtOH or indicated concentrations of 25HC for 24Â h, and cell viability was measured by CellTiterâ€�Glo (Promega). Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3.</p> </li> <li><span class="label" tagx="label" title="label">D</span><p>25HC does not affect VSV genome replication. Cell were infected with VSV pseudovirus encoding FLuc for 2Â h. Then, medium with EtOH or 25HC was added. At 24Â h postâ€�infection, cells were lysed, and luciferase activity was measured. VSV replication was quantified by luciferase assays. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3.</p> </li> <li><span class="label" tagx="label" title="label">E</span><p>7Î±â€�HC does not inhibit SARSâ€�CoV-2 entry. Following a 16â€�h incubation with EtOH or indicated concentrations of 7Î±â€�HC, cells were challenged with SARSâ€�CoV-2 pseudovirus encoding FLuc for 2Â h. At 24Â h postâ€�infection, cells were lysed, and luciferase activity was measured. Statistical analyses were conducted by Student's <i>t</i>â€�test. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. *<i>PÂ <div class="â_UNKNOWN" /></i>0.05.</p> </li> <li><span class="label" tagx="label" title="label">F</span><p>TMPRSS2 inhibitors camostat blocked entry of SARSâ€�CoV and MERSâ€�CoV pseudoviruses. Caluâ€�3 cells were treated with 10Â Î¼M camostat or DMSO for 1Â h. Then the cells were infected with SARSâ€�CoV or MERSâ€�CoV pseudovirus with EGFP for 1Â h. EGFP signals were captured by fluorescence microscope 24Â h postâ€�infection. Scale bar, 100Â Î¼m</p> </li> <li><span class="label" tagx="label" title="label">G</span><p>Hoechst stain of nuclei in FigÂ <a href="#embj2020106057-fig-0002">2</a>F. White arrows indicate syncytia. Scale bar, 50 Î¼m.</p> </li> <li><span class="label" tagx="label" title="label">H</span><p>25HC inhibits cellâ€"cell fusion on Vero cells. Vero cells were treated with EtOH or 25HC (5Â Î¼M) for 16Â h prior to transfection with pLVX plasmids encoding SARSâ€�CoV-2 S. After 4Â h, medium was changed and reâ€�supplemented with EtOH or 25HC. At 48Â h postâ€�transfection, syncytium formation was visualized after trypsin treatment by fluorescence microscopy. White arrows indicate syncytia. Scale bar, 50Â Î¼m. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. ***<i>P</i>Â <div class="â_UNKNOWN">
tâ€�test.</div></p> </li> <li><span class="label" tagx="label" title="label">I</span><p>Hoechst stain of nuclei in FigÂ <a href="#embj2020106057-fig-0002">2</a>G. White arrows indicate syncytia. Scale bar, 50Â Î¼m.</p> </li> </ul> <p />   </div> <p>We further tested restrictive potential of 25HC against two other human coronaviruses, SARSâ€�CoV and MERSâ€�CoV using VSV harboring SARSâ€�CoV S (FigsÂ <a href="#embj2020106057-fig-0002">2</a>C and <a href="#embj2020106057-fig-0002ev">EV2</a>F) and MERSâ€�CoV S (FigsÂ <a href="#embj2020106057-fig-0002">2</a>D and <a href="#embj2020106057-fig-0002ev">EV2</a>F). Entry of SARSâ€�CoV and MERSâ€�CoV pseudoviruses into Caluâ€�3 cells was suppressed by 25HC in a doseâ€�dependent manner as shown by luciferase assays, with IC<sub>50</sub>'s of 2.48Â Î¼M and 1.22Â Î¼M, respectively (FigÂ <a href="#embj2020106057-fig-0002">2</a>C and D, upper panels). This inhibition of infection was also confirmed by EGFPâ€�expressing pseudoviruses (FigÂ <a href="#embj2020106057-fig-0002">2</a>C and D, lower panels). These data, altogether, suggest that 25HC is an effective inhibitor of human coronaviruses entry.</p> <p>To determine which step of SARSâ€�CoVâ€�2 entry is restricted by 25HC, we examined the effect of 25HC on SARSâ€�CoVâ€�2 pseudovirus receptor binding and fusion with the plasma membrane. Binding assays were performed by treating Caluâ€�3 cells with 25HC prior to SARSâ€�CoVâ€�2 pseudovirus challenge at 4Â°C to prevent internalization, and the amount of bound virions after three washes was quantified by RTâ€"qPCR (FigÂ <a href="#embj2020106057-fig-0002">2</a>E). Our data indicate that 25HC does not significantly affect virus binding to the host cells (FigÂ <a href="#embj2020106057-fig-0002">2</a>E).</p> <p>Next, we investigated the effect of 25HC on virus fusion with target cells. To simulate viral envelope fusion with plasma membrane, we performed cellâ€"cell fusion studies by ectopically expressing SARSâ€�CoVâ€�2 S in EtOHâ€� or 25HCâ€�treated 293FT cells (FigsÂ <a href="#embj2020106057-fig-0002">2</a>F and <a href="#embj2020106057-fig-0002ev">EV2</a>G) and Vero E6 cells (FigÂ <a href="#embj2020106057-fig-0002ev">EV2</a>H) with EGFP to visualize spikeâ€�induced syncytia (Belouzard <i>etÂ al</i>, <a href="#embj2020106057-bib-0002">2009</a>). EtOHâ€�treated cells, but not 25HCâ€�treated cells, formed large multinucleate syncytia upon SARSâ€�CoVâ€�2 S expression (FigsÂ <a href="#embj2020106057-fig-0002">2</a>F and <a href="#embj2020106057-fig-0002ev">EV2</a>H). Since 25HC demonstrates broad antiâ€�human coronavirus activity, we asked whether 25HC could inhibit SARSâ€�CoVâ€�Sâ€�mediated and MERSâ€�CoVâ€�Sâ€�mediated cellâ€"cell fusion. Similar to SARSâ€�CoVâ€�2 S, ectopic expression of SARSâ€�CoVâ€�S and MERSâ€�CoVâ€�S in EtOHâ€�treated, but not 25HCâ€�treated cells, induced the formation of large syncytia (FigsÂ <a href="#embj2020106057-fig-0002">2</a>G and <a href="#embj2020106057-fig-0002ev">EV2</a>I). These results strongly support a function for 25HC in blocking human coronavirus spikeâ€�mediated fusion with the plasma membrane, thereby suppressing virus entry.</p> </div> <div class="25hcblockscoronavirusentryandspikeâ€�mediatedmembranefusionthroughmobilizingaccessiblecholesterolfromtheplasmamembrane" title="sec"> <div class="title" tagx="title" title="title">
25HC blocks coronavirus entry and spikeâ€�mediated membrane fusion through mobilizing accessible cholesterol from the plasma membrane</div> <p>25HC and other oxysterols are important modulators of cholesterol metabolism and homeostasis (Du <i>etÂ al</i>, <a href="#embj2020106057-bib-0011">2004</a>). Previous studies have demonstrated that 25HC changes the orientation and solvent accessibility of cholesterol and trigger cholesterol trafficking from the plasma membrane to the endoplasmic reticulum (Du <i>etÂ al</i>, <a href="#embj2020106057-bib-0011">2004</a>). Intriguingly, a recent study on <i>Listeria</i> infection of epithelial cells reveals that 25HC restricts <i>Listeria monocytogenes</i> cellâ€�toâ€�cell dissemination through mobilizing cholesterol molecules free of sequestration by proteins and lipids from the plasma membrane (Abrams <i>etÂ al</i>, <a href="#embj2020106057-bib-0001">2020</a>). These cholesterol molecules constitute a distinct accessible cholesterol pool (Das <i>etÂ al</i>, <a href="#embj2020106057-bib-0008">2014</a>). Considering that 25HC blocked human coronavirus fusion at the plasma membrane of lung epithelial cells, we hypothesized that 25HC could inhibit SARSâ€�CoVâ€�2 entry through depleting accessible cholesterol on the plasma membrane (FigÂ <a href="#embj2020106057-fig-0003">3</a>A). Since we postulate a viral entry mechanism at the plasma membrane and not via endosome, we first confirmed that SARSâ€�CoVâ€�2 enters lung epithelial cells primarily through fusion at the plasma membrane and not by endocytosis. We analyzed viral entry in Caluâ€�3 and Vero cells in the presence of inhibitors for TMPRSS2 and Cathepsin B/L and compared with DMSO control. We found that camostat mesylate, a TMPRSS2 inhibitor, dramatically reduced viral entry in Caluâ€�3 cells and not in Vero cells (FigÂ <a href="#embj2020106057-fig-0003ev">EV3</a>A and B). And cathepsin B/L inhibitor Eâ€�64d efficiently blocked viral entry in Vero cells without effecting Caluâ€�3 infection (FigÂ <a href="#embj2020106057-fig-0003ev">EV3</a>A and B). Therefore, the priming of spike triggering viral fusion is mediated by TMPRSS2 on the plasma membrane but not endosomal Cathepsin B/L. These results are consistent with previous findings that SARSâ€�2 Sâ€�driven entry requires TMPRSS2 in Caluâ€�3 cells, which likely directs the virus to an early route of entry through fusion at the plasma membrane, and endosomal cathepsins in Vero cells, which are associated with a late route of entry through fusion in the endosome (Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0015">2020b</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3</span></a></div>   <div class="title" tagx="title" title="title">
25â€�Hydrocholesterol (25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span>) inhibits viral entry through depleting accessible cholesterol on plasma membrane</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A</span><p>Rescue of cholesterol depletion on the plasma membrane (PM) reverses SARSâ€�CoV-2 entry block in Caluâ€�3 cells. 25HC induces the depletion of accessible cholesterol on the plasma membrane and supplement of additional cholesterol can reverse the depletion and viral entry.</p> </li> <li><span class="label" tagx="label" title="label">B, C</span><p>25HC depletes accessible cholesterol on the plasma membrane. (B) Caluâ€�3 cells were treated with indicated concentrations of 25HC for 1Â h and subsequently incubated with ALOD4 for 30Â min. Cell were washed twice with PBS, lysed, and the amounts of bound ALOD4 were examined by Western blotting. (C) Caluâ€�3 cells were treated with 5Â Î¼M 25HC for 1Â h, and subsequently incubated with AF488â€�labeled ALOD4 for 30Â min. Cells were washed twice and examined by fluorescence microscopy. Scale bar, 50Â Î¼m.</p> </li> <li><span class="label" tagx="label" title="label">D</span><p>Cholesterol rescues the level of accessible cholesterol on the plasma membrane of 25HCâ€�treated cells. Caluâ€�3 cells were pretreated with ethanol or 5Â Î¼M 25HC for 1Â h. Cells were washed and incubated with PBS or 20Â Î¼M cholesterol for 1Â h. After further incubation with ALOD4, cells were washed with PBS twice and lysed. The amount of bound ALOD4 was examined by Western blotting.</p> </li> <li><span class="label" tagx="label" title="label">Eâ€"H</span><p>Addition of cholesterol rescues entry of SARSâ€�CoV-2 pseudovirus, SARSâ€�CoV pseudovirus, and MERSâ€�CoV pseudovirus into 25HCâ€�treated Caluâ€�3 cells. Cells were pretreated with ethanol or 5Â Î¼M 25HC for 16Â h, washed, and incubated with PBS or 80Â Î¼M cholesterol for 1Â h prior to infection with SARSâ€�CoV-2 pseudovirus. Entry of SARSâ€�CoV-2 pseudovirus (E and F), SARSâ€�CoV pseudovirus (G), and MERSâ€�CoV pseudovirus (H) was assessed by luciferase assay or by fluorescence microscopy at 24Â h postâ€�infection. Scale bar, 100Â Î¼m. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. **<i>PÂ <div class="â_UNKNOWN" /></i>0.01, ***<i>PÂ <div class="â_UNKNOWN" /></i>0.001, ****<i>PÂ <div class="â_UNKNOWN" /></i>0.0001, by Student's <i>t</i>â€�test.</p> </li> </ul> <p /> <p><span class="named-content" title="named-content">Source data are available online for this figure.</span></p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure EV3</span></a></div>   <div class="title" tagx="title" title="title">
(related to FigÂ <a href="#embj2020106057-fig-0003">3</a>). Rescue of cholesterol depletion on the plasma membrane reverses <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 spikeâ€�mediated cellâ€"cell fusion</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A, B</span><p>SARS-CoVâ€�2 entry is dependent on TMPRSS2 but not endosomal cathepsin in lung epithelial cells. Caluâ€�3 cells were treated with 10Â Î¼M camostat or 25Â Î¼M Eâ€�64D for 1Â h. Then, the cells were infected with SARSâ€�CoV-2 pseudovirus with EGFP (A) or Fluc (B) for 1Â h. EGFP signals were captured by fluorescence microscope 24Â h postâ€�infection. Scale bar, 100Â Î¼m. Luciferase activity was measured at 24Â h postâ€�infection. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. ****<i>P</i>Â <div class="â_UNKNOWN">
tâ€�test.</div></p> </li> <li><span class="label" tagx="label" title="label">C</span><p>25HC depletes accessible cholesterol on the plasma membrane. Caluâ€�3 cells were treated with EtOH or 5Â Î¼M 25HC and subsequently incubated with 3 or 6Â Î¼M ALOD4 for 30Â min. The amount of bound ALOD4 was examined by Western blotting.</p> </li> <li><span class="label" tagx="label" title="label">D, E</span><p>Supplement of cholesterol can rescue cellâ€"cell fusion induced by SARSâ€�CoV-2 S. (D) 293FT cells were treated with EtOH or 25HC (5Â Î¼M) for 16Â h prior to transfection with pLVX plasmids encoding SARSâ€�CoV-2 S. 4Â h postâ€�transfection, medium was changed and reâ€�supplemented with EtOH or 25HC in the presence or absence of 80Â Î¼M cholesterol. 24Â h postâ€�transfection, syncytium formation was visualized by fluorescence microscopy. Scale bar, 50Â Î¼m. (E) Membrane fusion was quantified as the percentage of nuclei within syncytia out of all nuclei in GFPâ€�positive cells. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3, ***<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN">
tâ€�test.</div></div></p> </li> <li><span class="label" tagx="label" title="label">F</span><p>Synergistic effects of 25HC and TMPRSS2 inhibitor to block SARSâ€�CoV-2 entry. Addition of Nafamostat in 25HCâ€�treated cells were infected with SARSâ€�CoV-2 pseudovirus and 24Â h postâ€�infection, cells were lysed, and luciferase activity was measured. Statistical analyses were conducted by Student's <i>t</i>â€�test. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. **<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN"> </div></div></p></li> </ul> <p /> <p><span class="named-content" title="named-content">Source data are available online for this figure.</span></p>   </div> <p>Next, we determined if 25HC could deplete accessible cholesterol on the plasma membrane of Caluâ€�3 cells by incubating cells with domain 4 of anthrolysin O (ALOD4), a bacterial toxin that specifically traps accessible cholesterol at the plasma membrane (Das <i>etÂ al</i>, <a href="#embj2020106057-bib-0008">2014</a>; Abrams <i>etÂ al</i>, <a href="#embj2020106057-bib-0001">2020</a>). 25HC depletes accessible cholesterol at the plasma membrane in a doseâ€�dependent manner (FigsÂ <a href="#embj2020106057-fig-0003">3</a>B and <a href="#embj2020106057-fig-0003ev">EV3</a>C), which corroborated with the loss of fluorescence signal from AF488â€�labeled ALOD4 due to 25HC treatment (FigÂ <a href="#embj2020106057-fig-0003">3</a>C). To determine whether accessible cholesterol is essential for SARSâ€�CoVâ€�2 entry, we performed a functional cholesterol rescue experiment. We supplemented 25HCâ€�treated cells with exogenous cholesterol in cyclodextrin complex. We found that the depletion of accessible cholesterol could be rescued by supplementing soluble cholesterol to the cell culture (FigÂ <a href="#embj2020106057-fig-0003">3</a>D). If accessible cholesterol on the plasma membrane regulated by 25HC is essential for viral fusion, the replenishment of cholesterol should rescue viral fusion and lead to virus entry. As expected, supplementing cholesterol in 25HCâ€�treated cells rescued SARSâ€�CoVâ€�2 fusion and entry, but had no effect on vehicleâ€�treated cells (FigsÂ <a href="#embj2020106057-fig-0003">3</a>E and F, and <a href="#embj2020106057-fig-0003ev">EV3</a>D and E). These results provide evidence that 25HC mobilizes plasma membrane cholesterol to inhibit SARSâ€�CoVâ€�2 virusâ€"cell fusion.</p> <p>Given that 25HC inhibits viral entry of SARSâ€�CoV and MERSâ€�CoV (FigÂ <a href="#embj2020106057-fig-0002">2</a>C and D), we asked whether such inhibition was achieved through the same mechanism as described above for SARSâ€�CoVâ€�2. To address this question, Caluâ€�3 cells were pretreated with ethanol or 25HC and challenged with SARSâ€�CoV or MERSâ€�CoV pseudoviruses with or without a prior supplement of cholesterol. Addition of cholesterol reversed the inhibitory function of 25HC on viral entry for both SARSâ€�CoV and MERSâ€�CoV pseudoviruses (FigÂ <a href="#embj2020106057-fig-0003">3</a>G and H). Altogether, our results show that 25HC restricts coronavirus entry by depleting accessible cholesterol on the plasma membrane.</p> </div> <div class="25hcdepletesaccessiblecholesterolontheplasmamembranethroughactivatingacylâ€�coa:cholesterolacyltransferase(acat)" title="sec"> <div class="title" tagx="title" title="title">
25HC depletes accessible cholesterol on the plasma membrane through activating acylâ€�CoA:cholesterol acyltransferase (ACAT)</div> <p>Next, we sought to elucidate the mechanism of cholesterol mobilization induced by 25HC. 25HC enhances cholesterol esterification and in turns trigger cholesterol transport from the plasma membrane to the ER (Du <i>etÂ al</i>, <a href="#embj2020106057-bib-0011">2004</a>; Das <i>etÂ al</i>, <a href="#embj2020106057-bib-0008">2014</a>). We hypothesized that the enzyme catalyzing the esterification of cholesterol, ACAT, can be activated by 25HC and SARSâ€�CoVâ€�2 to direct the trafficking of cholesterol from the plasma membrane. To test this hypothesis, we employed the selective ACAT inhibitor, Sandoz 58â€�035 (SZ58â€�035), to determine the role of ACAT in modulating accessible cholesterol and suppressing SARSâ€�CoVâ€�2 pseudovirus entry (FigÂ <a href="#embj2020106057-fig-0004">4</a>A). Since upon esterification by ACAT, cholesteryl esters are stored in cytosolic lipid droplets, we used a lipid droplet stain to monitor ACAT activity (Dong <i>etÂ al</i>, <a href="#embj2020106057-bib-0010">2020</a>). We first confirmed that 25HC could activate ACAT by staining intracellular lipid droplets in vehicleâ€� or 25HCâ€�treated Caluâ€�3 cells. We found a dramatic increase in lipid droplets in 25HCâ€�treated cells, indicating an increased ACATâ€�mediated cholesterol esterification (FigÂ <a href="#embj2020106057-fig-0004">4</a>B). Next, we treated vehicleâ€� or 25HCâ€�conditioned Caluâ€�3 cells with or without SZ58â€�035 and analyzed accessible cholesterol at the plasma membrane by ALOD4. Our results showed that when ACAT was inhibited, accessible cholesterol was increased suggesting that SZ58â€�35 stalls the depletion of accessible cholesterol by 25HC (FigÂ <a href="#embj2020106057-fig-0004">4</a>C). In accordance with these observations, SZ58â€�035 treatment rescued SARSâ€�CoVâ€�2 pseudovirus entry (FigÂ <a href="#embj2020106057-fig-0004">4</a>D and E). Furthermore, we infected Caluâ€�3 cells with the SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 strain and analyzed lipid droplet formation. Our results showed that authentic virus infection efficiently activated ACAT that was comparable to 25HC treatment (FigÂ <a href="#embj2020106057-fig-0004ev">EV4</a>). To further define the specificity of ACAT inhibition and its effect on viral entry, we silenced ACAT by shRNAs and analyzed pseudovirus entry in the presence and absence of 25HC. We found that ACAT knockdown by shRNA enhanced pseudovirus entry into 25HCâ€�treated Caluâ€�3 cells compared to nonâ€�targeting shRNA (FigÂ <a href="#embj2020106057-fig-0004">4</a>F), a finding similar to drug mediated inhibition of ACAT (FigÂ <a href="#embj2020106057-fig-0004">4</a>D).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4</span></a></div>   <div class="title" tagx="title" title="title">
25â€�Hydrocholesterol (25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span>) activates acylâ€�CoA:cholesterol acyltransferase (<span class="styled-content" tagx="styled-content" title="styled-content">ACAT</span>) and induces internalization of accessible cholesterol from the plasma membrane</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A</span><p>Inhibition of cholesterol mobilization from the plasma membrane by the ACAT inhibitor SZ58â€�035.</p> </li> <li><span class="label" tagx="label" title="label">B</span><p>25HC activates ACAT and stimulates the formation of lipid droplets. Caluâ€�3 cells were cultured in medium containing 2% LPDS prior to the treatment of ethanol or 5Â Î¼M 25HC for 16Â h. Subsequently, cells were stained by LipidSpot to visualize intracellular lipid droplets. Scale bar, 50Â Î¼m.</p> </li> <li><span class="label" tagx="label" title="label">C</span><p>SZ58â€�035 rescues surface accessible cholesterol in 25HCâ€�treated cells. Caluâ€�3 cells were treated with vehicle or 40Â Î¼M SZ58â€�035 for 16Â h, prior to treatment with ethanol or 2.5Â Î¼M 25HC for 1Â h. Cells were then incubated with ALOD4 for 30Â min. The amount of bound ALOD4 was examined by Western blotting.</p> </li> <li><span class="label" tagx="label" title="label">D, E</span><p>Inhibition of ACAT activity by SZ58â€�035 rescues viral entry viral entry. Caluâ€�3 cells were pretreated with ethanol or 5Â Î¼M 25HC for 16Â h in the presence of DMSO or 40Â Î¼M SZ58â€�035. Then, cells were washed and incubated with DMSO or 40Â Î¼M SZ58â€�305 for 1Â h prior to infection with SARSâ€�CoV-2 pseudovirus. Luciferase activity was measured at 24â€�hour postâ€�infection (D). EGFP signal was captured by fluorescence microscope 24Â h postâ€�infection (E). Scale bar, 100Â Î¼m. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. ****<i>P</i>Â <div class="â_UNKNOWN">
tâ€�test.</div></p> </li> <li><span class="label" tagx="label" title="label">F</span><p>Knockdown of ACAT1/2 rescues SARSâ€�CoV-2 pseudovirus entry in 25HCâ€�treated cells. Caluâ€�3 cells were transduced with lentiviral vectors carrying nonâ€�targeting shRNA or shRNAs targeting ACAT1 and ACAT2. 48Â h postâ€�transduction, cells were treated with ethanol or 5Â Î¼M 25HC for 16Â h. Then, the cells were challenged with SARSâ€�CoV-2 pseudovirus. 24Â h postâ€�pseudovirus challenge, viral entry was quantified by luciferase assays. Bar represents meanÂ Â±Â SD of <i>n</i>Â =Â 3. **<i>P</i>Â <div class="â_UNKNOWN">
PÂ <div class="â_UNKNOWN">
tâ€�test.</div></div></p> </li> </ul> <p /> <p><span class="named-content" title="named-content">Source data are available online for this figure.</span></p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure EV4</span></a></div>   <div class="title" tagx="title" title="title">
(related to FigÂ <a href="#embj2020106057-fig-0004">4</a>). <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 isolate <span class="styled-content" tagx="styled-content" title="styled-content">USA</span>â€�<span class="styled-content" tagx="styled-content" title="styled-content">WA</span>1/2020 activates <span class="styled-content" tagx="styled-content" title="styled-content">ACAT</span></div> <p>Caluâ€�3 cells were infected with SARSâ€�CoVâ€�2 USAâ€�WA1/2020 at MOIÂ =Â 2 for 24Â h at 37Â°C or treated with 5Â Î¼M 25HC for 24Â h. Cells were then stained with 1X LipidSpot 488 for 30Â min. Fluorescence intensity was quantified by Incucyte S3 analysis software. Scale bar, 200Â Î¼m.</p>   </div> <p>Collectively, these results show that ACAT is activated in response to 25HC and triggers the mobilization of accessible cholesterol from the plasma membrane, thereby restricting SARSâ€�CoVâ€�2 entry.</p> </div> <div class="25hcinhibitssarsâ€�covâ€�2isolateusaâ€�wa1/2020infectionandviralentryinhumanlungorganoids" title="sec"> <div class="title" tagx="title" title="title">
25HC inhibits SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 infection and viral entry in human lung organoids</div> <p>To further confirm the antiviral activity of 25HC during a patient isolated SARSâ€�CoVâ€�2 infection, Caluâ€�3 cells were treated with a concentration gradient of 25HC and SARSâ€�CoVâ€�2 USAâ€�WA1/2020 infection was quantified by evaluating viral RNA of the infected cells and their culture supernatants (FigÂ <a href="#embj2020106057-fig-0005">5</a>A and B). Viral infection was inhibited by 25HC in a doseâ€�dependent manner. The IC50 values, as determined by supernatant viral RNA and intracellular viral RNA, are 382Â nM and 363Â nM, respectively (FigÂ <a href="#embj2020106057-fig-0004">4</a>A and B), which are quite similar to the IC50 for the inhibition of SARSâ€�CoVâ€�2 pseudovirus infection in Caluâ€�3 cells (FigÂ <a href="#embj2020106057-fig-0002">2</a>A). Supernatants of infected 25HCâ€�treated cultures also contain significantly less virus progeny than vehicle control (FigÂ <a href="#embj2020106057-fig-0005">5</a>C). Because organoids are more physiologically relevant than cell lines as infection models, we next sought to confirm the function of 25HC using 3D lung organoids. Human iPSC derived lung organoids were generated using previously published methods (Leibel <i>etÂ al</i>, <a href="#embj2020106057-bib-0016">2019</a>; Miller <i>etÂ al</i>, <a href="#embj2020106057-bib-0023">2019</a>) and characterized by analyzing expression of ACE2, TMPRSS2, and alveolar cell epithelial markers (SFTPC, SFTPB, HOPX; Tiwari etÂ al. Manuscript under preparation). These 60D differentiated lung organoids were pretreated overnight with 25HC (5Â Î¼M) and were challenged with luciferaseâ€�expressing SARSâ€�CoVâ€�2 pseudovirus. After 24Â h, luciferase activity was measured to quantify viral levels. 25HC treatment significantly blocked SARSâ€�CoVâ€�2 entry in lung organoids (FigÂ <a href="#embj2020106057-fig-0005">5</a>D). Altogether, results from lung epithelial cells and organoids further support that 25HC efficiently blocks SARSâ€�CoVâ€�2 entry in lung cells.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5</span></a></div>   <div class="title" tagx="title" title="title">
25â€�Hydrocholesterol (25<span class="styled-content" tagx="styled-content" title="styled-content">HC</span>) inhibits <span class="styled-content" tagx="styled-content" title="styled-content">SARS</span>â€�CoVâ€�2 isolate <span class="styled-content" tagx="styled-content" title="styled-content">USA</span>â€�<span class="styled-content" tagx="styled-content" title="styled-content">WA</span>1/2020 infection and viral entry in human lung organoids</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">A, B</span><p>25HC inhibits SARSâ€�CoV-2 USAâ€�WA1/2020 strain infection in Caluâ€�3 cells. Cells were pretreated with ethanol or 25HC followed by infection. At 48Â h postâ€�infection, RNA from supernatant (A) and infected cells (B) were extracted and quantified by qPCR. Data are meanÂ Â±Â SD of <i>n</i>Â =Â 3, representative of 3 repeats.</p> </li> <li><span class="label" tagx="label" title="label">C</span><p>Progeny virus titer in supernatant was quantified by plaque assays. Data are meanÂ Â±Â SD of <i>n</i>Â =Â 3, representative of 3 repeats. *<i>P</i>Â <div class="â_UNKNOWN">
tâ€�test.</div></p> </li> <li><span class="label" tagx="label" title="label">D</span><p>Twoâ€�monthâ€�old differentiated lung organoids were pretreated with 25HC (5Â Î¼M) for 16Â h and infected with luciferaseâ€�expressing SARSâ€�CoV-2 pseudovirus at MOIÂ =Â 0.1 for 2Â h and treated with fresh medium containing 5Â Î¼M 25HC. Luciferase activity was measured at 24Â h postâ€�infection. MeanÂ Â±Â SD of <i>n</i>Â =Â 3. ****<i>PÂ <div class="â_UNKNOWN" /></i>0.0001, by Student's <i>t</i>â€�test.</p> </li> </ul> <p />   </div> </div> </div> <div class="discussion" title="sec"> <div class="title" tagx="title" title="title">
Discussion</div> <p>In this study, we characterized the antiâ€�SARSâ€�CoVâ€�2 function and mechanism of <i>CH25H</i>, an interferonâ€�inducible gene robustly upâ€�regulated in lung epithelial cell lines infected with SARSâ€�CoVâ€�2 and in COVIDâ€�19â€�infected patients. We further showed that 25HC, the product of the interferonâ€�inducible enzyme CH25H, possesses broadâ€�spectrum antiviral activity against human coronaviruses. Further mechanistic studies revealed viral membrane fusion was blocked by this oxysterol. Previous studies demonstrated that 25HC inhibited entry of various types of viruses including VSV, HIV, NiV, EBOV, and ZIKV (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>; Li <i>etÂ al</i>, <a href="#embj2020106057-bib-0017">2017</a>). However, the mechanism by which 25HC modulates viral entry is still unknown. In addressing the mechanism of 25HC function, we found that 25HC triggered the depletion of accessible cholesterol from the plasma membrane via activating ACAT, thereby leading to inhibition of virus entry. The ERâ€�localized enzyme ACAT uses fatty acylâ€�CoA and cholesterol as substrates to produce cholesteryl esters for storage in cytoplasmic lipid droplets and induces the depletion of accessible cholesterol from the plasma membrane through unknown mechanisms (Abrams <i>etÂ al</i>, <a href="#embj2020106057-bib-0001">2020</a>). Altogether, our results provide evidence for a functional link between SARSâ€�CoVâ€�2 induced upâ€�regulation of <i>CH25H</i> and the inhibition of SARSâ€�CoVâ€�2 entry by the CH25H product 25HC and reveal the broadâ€�spectrum antiviral mechanism of this oxysterol.</p> <p>Sterols and oxysterols influence immune system and viral infections through both general and cellâ€�specific mechanisms (Spann &amp;amp; Glass, <a href="#embj2020106057-bib-0028">2013</a>). Cholesterol has multiple functions on lipid bilayers. An increase or decrease of cholesterol can be accompanied by changes in the fluidity, polarity, thickness, and intrinsic curvature of membrane. Changes in cholesterol could affect the function of integral membrane proteins, including viral receptor or coâ€�receptors, by altering their conformation or distribution on the plasma membrane (Yang <i>etÂ al</i>, <a href="#embj2020106057-bib-0034">2016</a>). These alterations will directly or indirectly affect virusâ€"cell membrane fusion, which is essential for viral genome release (Chazal &amp;amp; Gerlier, <a href="#embj2020106057-bib-0005">2003</a>). The depletion of cholesterol by 25HC did not affect viral binding and TMPRSS2 priming (FigsÂ <a href="#embj2020106057-fig-0002">2</a>E and <a href="#embj2020106057-fig-0003ev">EV3</a>F). It is possible the depletion of cholesterol directly affects virusâ€"cell fusion. Given the importance of membrane cholesterol for virusâ€"cell fusion, the mechanism of 25HC could possibly be extended to other viruses that fuse with a cellular membrane before entry. Indeed, cholesterol has been proved to be important for the fusion and postâ€�entry steps in the flavivirus life cycle (Osunaâ€�Ramos <i>etÂ al</i>, <a href="#embj2020106057-bib-0024">2018</a>). Depletion of cholesterol blocked HIV fusion at the plasma membrane (Yang <i>etÂ al</i>, <a href="#embj2020106057-bib-0033">2015</a>). Given that 25HC seems to inhibit the entry of multiple enveloped viruses, we speculate that enveloped viruses inhibited by 25HC at the fusion step utilize our proposed mechanism, suggesting a fundamental role for this small molecule in the innate immune system (Liu <i>etÂ al</i>, <a href="#embj2020106057-bib-0019">2013</a>).</p> <p>The COVIDâ€�19 pandemic is spreading and causing great human loss and suffering, but no vaccine or effective therapeutic strategy is available. It is urgent to develop antiviral drugs against SARSâ€�CoVâ€�2. Statins are commonly used as lipidâ€�lowering drugs that also have antiâ€�inflammatory effects; therefore, use of statin has been suggested for COVIDâ€�19 treatment (Castiglione <i>etÂ al</i>, <a href="#embj2020106057-bib-0004">2020</a>; Dashtiâ€�Khavidaki &amp;amp; Khalili, <a href="#embj2020106057-bib-0009">2020</a>). However, some studies suggest that the expression of ACE2 receptor, which is required for SARSâ€�CoVâ€�2 entry (Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0015">2020b</a>), is also upâ€�regulated by statins (Tikoo <i>etÂ al</i>, <a href="#embj2020106057-bib-0030">2015</a>; Shin <i>etÂ al</i>, <a href="#embj2020106057-bib-0027">2017</a>) raising concerns about the use of statin for COVIDâ€�19 therapy. Intriguingly, a retrospective clinical study on 13,981 patients found that statin use was associated with reduced risk of mortality in COVIDâ€�19â€�infected patients (Zhang <i>etÂ al</i>, <a href="#embj2020106057-bib-0036">2020</a>). Compared with statins, 25HC only decreases accessible cholesterol at the plasma membrane without altering the total cellular cholesterol; therefore, it may cause lower cytotoxicity or side effects than statin use. For example, we did not observe any significant increase in <i>ACE2</i> and <i>TMPRSS2</i> mRNA expression by 25HC treatment of Caluâ€�3 cells. In addition, 25HC is a natural product and has not shown toxicity in mice and nonâ€�human primates at effective concentrations. Thus, 25HC has potential as an antiviral agent to combat with SARSâ€�CoVâ€�2 and other possible emerging coronaviruses in the future.</p> </div> <div class="materialsandmethods" title="sec"> <div class="title" tagx="title" title="title">
Materials and Methods</div> <div class="cellcultureandreagents" title="sec"> <div class="title" tagx="title" title="title">
Cell culture and reagents</div> <p>All studies were performed in accordance with approved IRB protocols by the University of California (UCSD), San Diego. Human lung epithelia cell line Caluâ€�3, human colon epithelia cell line Cacoâ€�2 were obtained from ATCC. Caluâ€�3 was maintained in MEM medium supplemented with 1Ã—Â NEAA, penicillinâ€�streptomycin (100Â IU/ml), and 10% FBS. Cacoâ€�2 was cultured in MEM medium with 1Ã—Â NEAA, penicillinâ€�streptomycin (100Â IU/ml) and 20% FBS. 293FT and Vero E6 cells were maintained in DMEM medium with 10% FBS. Spike antibody recognizing S2 subunit of SARSâ€�CoV and SARSâ€�CoVâ€�2 was purchased from Nouvs (NB100â€�56578). Antiâ€�VSV M antibody was from EMD Millipore (MABF2347). EK1 peptides were obtained from Phoenix Pharma. Luciferase assay kit was purchased from Promega. 7Î±â€�HC, 25HC, waterâ€�soluble cholesterol, and Sandoz 58â€�035 were obtained from Sigma. Camostat, nafamostat and Eâ€�64d were purchased from Selleck Chemicals.</p> </div> <div class="vsvpseudovirusrescue,amplificationandtitration" title="sec"> <div class="title" tagx="title" title="title">
VSV pseudovirus rescue, amplification and titration</div> <p>Pseudo typed VSV was generated based on previously described work (Whitt, <a href="#embj2020106057-bib-0032">2010</a>). In brief, BHKâ€�21/WIâ€�2 cells were infected with vTF7â€�3 expressing T7 polymerase for 45Â min and then transfected with pVSVâ€�EGFPâ€�dG (addgene 31842) or pVSVâ€�FLucâ€�dG, along with pBS vectors expressing VSVâ€�N, VSVâ€�P, VSVâ€�L, and VSVâ€�G (Kerafast) at ratio 3:3:5:1:8, using Optiâ€�MEM and Lipofectamine 3000 according to the manufacturersâ€™ instructions. 48Â h postâ€�transfection, culture supernatants were collected and filtered through 0.22Â Î¼m filters to remove residual vaccinia virus. 293FT cells transfected with pMD2.G (addgene 12259) encoding VSVâ€�G for 24Â h were inoculated with the filtrate to amplify the VSV pseudovirus. 24Â h postâ€�inoculation, supernatants were collected and either stored at âˆ’80Â°C. Titration of EGFPâ€�expressing pseudovirus was performed by inoculating Vero E6 cells seeded in 96â€�well plates with 10â€�fold serial dilutions of the virus stock. 24Â h postâ€�inoculation, numbers of GFPâ€�positive cells were counted and used to calculate virus titer as infectious unit per milliliter (IU/ml). Titration of FLucâ€�expressing pseudoviruses was performed by inoculating Vero E6 cells transfected with VSVâ€�G in 24â€�well plates with 10â€�fold serial dilutions of the virus stock. 1Â h postâ€�inoculation, new medium containing 1.5% methylcellulose was used to replace the inoculum. 2Â days postâ€�inoculation, cells were washed and stained with crystal violet. Plaque numbers were counted and used to calculate virus titer.</p> </div> <div class="sarsâ€�covâ€�2,sarsâ€�cov,andmersâ€�covpseudovirusproduction,titration,andcharacterization" title="sec"> <div class="title" tagx="title" title="title">
SARSâ€�CoVâ€�2, SARSâ€�CoV, and MERSâ€�CoV pseudovirus production, titration, and characterization</div> <p>293FT cells were transfected with pLVX expressing SARSâ€�CoVâ€�2â€�S, SARSâ€�CoVâ€�S, or MERSâ€�CoVâ€�S. Nineteen amino acids at the C terminus of SARSâ€�CoVâ€�2â€�S and SARSâ€�CoVâ€�S was deleted, given previous report that the shortened mutant has improved incorporation into the pseudovirus envelope (Fukushi <i>etÂ al</i>, <a href="#embj2020106057-bib-0013">2005</a>; Hoffmann <i>etÂ al</i>, <a href="#embj2020106057-bib-0014">2020a</a>). At 24Â h postâ€�transfection, cells were infected with VSV pseudovirus containing Fluc or EGFP. Cells were washed four times with medium 1Â h postâ€�inoculation and maintained in medium for 24Â h. Then supernatant containing pseudovirus was collected, centrifuged, and used or stored at âˆ’80Â°C. The titer was measured using the same method for VSV pseudovirus mentioned above. To characterize the pseudovirus, 1Â ml supernatant was concentrated by ultraâ€�centrifugation at 106,750Â Ã—Â <i>g</i> for 2Â h at 4Â°C. Then, 40Â Î¼l lysate buffer with SDS was added and heated for 5Â min at 95Â°C. The samples were subjected to SDSâ€"PAGE and immunoblotting using spike antibody and VSV matrix antibody.</p> </div> <div class="sarsâ€�covâ€�2,sarsâ€�cov,andmersâ€�covpseudovirusinfectionandinhibitorstreatment" title="sec"> <div class="title" tagx="title" title="title">
SARSâ€�CoVâ€�2, SARSâ€�CoV, and MERSâ€�CoV pseudovirus infection and inhibitors treatment</div> <p>Cells were pretreated with 25HC for 16Â h and then infected with SARSâ€�CoVâ€�2, SARSâ€�CoV, and MERSâ€�CoV pseudovirus in fresh medium without 25HC. After 2â€�h infection, virus was removed and fresh medium without 25HC was added. For pseudovirus with Fluc, cells were lysed at 24Â h postâ€�infection and subjected for luciferase activity assay according to manufacturer's instruction. For pseudovirus with EGFP, infected was evaluated by taking picture for at least 5 random fields at 24Â h postâ€�infection.</p> </div> <div class="cellâ€" title="sec"> <div class="title" tagx="title" title="title">
Cellâ€"cell fusion assay</div> <p>293FT or Vero E6 cells were treated with EtOH or 25HC overnight, and then coâ€�transfected with pEGFPâ€�C1 and a pLVX vector expressing one of SARSâ€�CoVâ€�2â€�S, SARSâ€�CoVâ€�S, and MERSâ€�CoVâ€�S using Lipofectamine 3000, in the absence of EtOH or 25HC. 4Â h postâ€�transfection, fresh medium containing EtOH and 5Â Î¼M 25HC was supplemented. For 293FT cells, 24Â h postâ€�transfection, cells were stained with Hoechst for 10Â min at 37Â°C and examined under Leica fluorescence microscope (DMI 3000). For Vero E6 cell, 48Â h postâ€�transfection, cells were washed twice with PBS, and incubated with 2Â Î¼g/ml Trypsin in PBS for 20Â min. Trypsinâ€�containing PBS was subsequently removed, and cells were further incubated in medium for 40Â min, prior to a 10â€�min Hoechst staining at 37Â°C and examination under a fluorescence microscope. For quantification of membrane fusion, the percentage of nuclei involved in syncytia formation in each group was calculated by averaging three corresponding fields, and the extent of membrane fusion for each group was calculated by averaging 3 independent biological replicates for that group.</p> </div> <div class="pseudovirusbindingassay" title="sec"> <div class="title" tagx="title" title="title">
Pseudovirus binding assay</div> <p>Caluâ€�3 cells were treated with EtOH or indicated concentrations of 25HC for 16Â h, prior to incubation with SARSâ€�CoVâ€�2 pseudovirus at MOIÂ =Â 2 at 4Â°C. Cells were then washed with chilled PBS three times and lysed with TRIzol. The RNA was extracted using a Directâ€�zol RNA Kit (Zymo). The amount of bound virions was measured by RTâ€"qPCR using primers for VSVâ€�L. The primers are as follows: <i>GAPDH</i> (Forward: GGCCTCCAAGGAGTAAGACC; Reverse: AGGGGTCTACATGGCAACTG), <i>VSV</i>â€�<i>L</i> (Forward: GACGGGCTCATCAGTCTATTT; Reverse: GGATACCTCACTCCTCACAATC).</p> </div> <div class="alod4proteinpurification,labeling,andincubation" title="sec"> <div class="title" tagx="title" title="title">
ALOD4 protein purification, labeling, and incubation</div> <p>ALOD4 protein was expressed, purified, and labeled based on a previously described protocol (Endapally <i>etÂ al</i>, <a href="#embj2020106057-bib-0012">2019</a>). Briefly, the plasmid pALOD4 (Addgene 111026) was transformed into BL21(DE3)pLysS competent cells (Invitrogen) (Gay <i>et al</i>, <a href="#embj2020106057-bib-0501">2015</a>). ALOD4â€�His<sub>6</sub> was purified using Capturem Hisâ€�tagged purification kit (Takara). The purified protein was further concentrated by 10Â kD Amicon Ultra centrifugal filters. For ALOD4 labeling by Alexa Fluor 488 C5 (AF488) (Invitrogen), ALOD4 was mixed with AF488 at 4Â°C for 16Â h. The reaction was quenched by 10Â mM DTT. Excess dye was removed by desalting.</p> <p>For ALOD4 binding assay, 3Â Î¼M purified or labeled ALOD4 was added to each well, and ethanolâ€� or 25HCâ€�treated cells were incubated with ALOD4 for 30Â min at 37Â°C. Cells were washed twice with PBS prior to WB sample preparation. For ALOD4 binding assay with cholesterol rescue, ethanolâ€� and 25HCâ€�treated cells were treated with cholesterol for 1Â h at 37Â°C prior to incubation with ALOD4. For ALOD4 binding assay with SZ58â€�035, vehicle or SZ58â€�035 was present during the treatment with 25HC and incubation with ALOD4.</p> </div> <div class="cholesterolandsandoz58â€�035rescueassays" title="sec"> <div class="title" tagx="title" title="title">
Cholesterol and Sandoz 58â€�035 rescue assays</div> <p>Caluâ€�3 cells were pretreated with Ethanol or 5Â Î¼M 25HC for 16Â h. For cholesterol rescue experiment, the cells were washed and incubated with PBS or 80Â Î¼M waterâ€�soluble cholesterol for 1Â h. Fresh medium and SARSâ€�CoVâ€�2 pseudovirus without compounds were added to incubate with the cells for 2Â h. Then, cells were washed and cultured in fresh medium. For Sandoz 58â€�035 rescue experiment, after overnight treatment of 25HC in the presence of DMSO or 40Â Î¼M SZ58â€�035, Caluâ€�3 cells were washed and incubated with DMSO or 40Â Î¼M SZ58â€�035 for 1Â h prior to infection with SARSâ€�CoVâ€�2 pseudovirus. For pseudovirus with Fluc, the cells were lysed and subjected to luciferase activity measurement at 24Â h postâ€�infection. For EGFP pseudovirus, EGFP signals were captured by fluorescence microscope at 24Â h postâ€�infection.</p> </div> <div class="acatknockdownrescueassays" title="sec"> <div class="title" tagx="title" title="title">
ACAT knockdown rescue assays</div> <p>Caluâ€�3 cells were transduced with lentivirus expressing shACAT1/2 for 48Â h. Then, cells were treated with medium containing EtOH or 5Â Î¼M 25HC overnight. Caluâ€�3 cells were washed prior to infection with SARSâ€�CoVâ€�2 pseudovirus. The cells were lysed and subjected to luciferase activity measurement at 24Â h postâ€�infection.</p> </div> <div class="sarsâ€�covâ€�2isolateusaâ€�wa1/2020infection" title="sec"> <div class="title" tagx="title" title="title">
SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 infection</div> <p>SARSâ€�CoVâ€�2 isolate USAâ€�WA1/2020 was obtained from BEI Resources. SARSâ€�CoVâ€�2 was propagated and infectious units quantified by plaque assay using Vero E6 cells. Caluâ€�3 cells were pretreated with 25HC overnight and then infected with SARSâ€�CoVâ€�2 at MOIÂ =Â 0.1 for 1Â h at 37Â°C. Then, cells were washed and fresh medium with 25HC was supplemented. 48Â h postâ€�infection, supernatant and infected cells were lysed using TRIzol and RNA was extracted using a Directâ€�zol RNA Kit (Zymo) and quantified by RTâ€"qPCR using SARSâ€�CoVâ€�2Â N primers. The primers are as follows: <i>SARSâ€�CoV-2â€�N</i> (Forward: CACATTGGCACCCGCAATC; Reverse: GAGGAACGAGAAGAGGCTTG). Viral titer in supernatant was quantified by plaque assay in Vero cells.</p> </div> <div class="lipiddropletstaining" title="sec"> <div class="title" tagx="title" title="title">
Lipid droplet staining</div> <p>Caluâ€�3 cells were suspended in MEM medium with 2% lipid depleted serum and seeded in the wells of a Labâ€�TEK II 4â€�well chamber or a 96â€�well plate. For the treatment with 25HC, cells were treated with 5Â Î¼M 25HC for 16Â h. Then, the cells were washed and stained with 1Ã— LipidSpot 488 (Biotium) for 30Â min. The signals were captured by fluorescence microscope. For the infection with live SARSâ€�CoVâ€�2 virus, Caluâ€�3 cells were infected with SARSâ€�CoVâ€�2 USAâ€�WA1/2020 at MOIÂ =Â 2 for 1Â h at 37Â°C. Then, cells were washed, and fresh medium was supplemented. Cells were stained with 1Ã— LipidSpot 488 for 30Â min after 24Â h postâ€�infection. The fluorescence signal was captured by Incucyte S3.</p> </div> <div class="lungorganoid25hctreatmentandinfection" title="sec"> <div class="title" tagx="title" title="title">
Lung Organoid 25HC treatment and infection</div> <p>Human iPSC derived lung organoids were generated using previously published methods (Leibel <i>etÂ al</i>, <a href="#embj2020106057-bib-0016">2019</a>; Miller <i>etÂ al</i>, <a href="#embj2020106057-bib-0023">2019</a>) and characterized by expression of ACE2, TMPRSS2 and alveolar cell epithelial markers (SFTPC, SFTPB, HOPX) (Tiwari <i>etÂ al</i>, Manuscript under preparation). These 60D differentiated lung organoids were pretreated overnight with 25HC (5Â Î¼M) and were infected with luciferaseâ€�expressing SARSâ€�CoVâ€�2 pseudovirus (100Â Î¼l). At 2Â h postâ€�infection, organoids were incubated with fresh medium containing 25HC. After 24Â h, luciferase activity was measured to quantify viral infection.</p> </div> <div class="lentivirusproductionandtransduction" title="sec"> <div class="title" tagx="title" title="title">
Lentivirus production and transduction</div> <p>Two sgRNA oligos targeting ACE2 were cloned into lentiCRISPR v2 (addgene 52961) and two shRNA oligos targeting ACAT1 and ACAT2 were cloned into pLKO.1 (addgene 8453). <i>CH25H</i> was cloned into pLVX vectors. The target sequences of sgRNA and shRNA are asÂ follows: <i>ACE2</i>â€�sgRNA1: CAGGATCCTTATGTGCACAA; <i>ACE2</i>â€�sgRNA2: CCAAAGGCGAGAGATAGTTG; <i>ACAT1</i>â€�shRNA: GCCACTAAGCTTGGTTCCATT; <i>ACAT2</i>â€�shRNA: GCTCTTATGAAGAAGTCAGAA. The cloning primers for CH25H (Forward: GGATCTATTTCCGGTGAATTCATGAGCTGCCACAACTGCTCC; Reverse: GCGGTCATACGTAGGATCCTTACCGCGCTGGGACAGATG). 293FT cells seeded in 6â€�well plates were coâ€�transfected with pMD2.G (0.6Â Î¼g), psPAX.2 (1.2Â Î¼g), and sgRNA, pLVX, or pLKO.1 vector (1.8Â Î¼g) using Optiâ€�MEM and Lipofectamine 3000 according to the manufacturersâ€™ instruction. At 4Â h postâ€�transfection, supernatant was replaced with fresh medium. At 48Â h postâ€�transfection, supernatant was harvested and used to transduce Caluâ€�3 cells. After 12Â h transduction, lentivirus was removed and replaced with fresh medium.</p> </div> <div class="cellviabilityassay" title="sec"> <div class="title" tagx="title" title="title">
Cell viability assay</div> <p>Caluâ€�3 or Cacoâ€�2 cells were treated with EtOH or twofold serialÂ dilutions of 25HC for 48Â h. Cells were then examined for ATP levels using CellTiterâ€�Glo (Promega) according to the manufacturer's instruction.</p> </div> <div class="westernblotandantibodies" title="sec"> <div class="title" tagx="title" title="title">
Western blot and antibodies</div> <p>Cell lysates were subject to SDSâ€"PAGE on 4â€"20% Bisâ€�Tris gels and transferred to PVDF membranes. Pierce Fast Western Blot Kit (Thermo Scientific) was used to perform immunoblot according to the manufacturer's instructions with the following antibodies: mouse antiâ€�Hisâ€�tagged (Millipore 05â€�949) and HRPâ€�conjugated mouse antiâ€�tubulin (Proteintech HRPâ€�66031). Chemiluminescence of antiâ€�Hisâ€�tagged antibody was performed withÂ SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific).</p> </div> <div class="rnaâ€�seqanalysisfromsarsâ€�covâ€�2â€�infectedcellsandcovidâ€�19â€�infectedpatients" title="sec"> <div class="title" tagx="title" title="title">
RNAâ€�seq analysis from SARSâ€�CoVâ€�2â€�infected cells and COVIDâ€�19â€�infected patients</div> <p>For the RNAâ€�seq data from SARSâ€�CoVâ€�2, IAV, HPIV3, and RSV infection (Blancoâ€�Melo <i>etÂ al</i>, <a href="#embj2020106057-bib-0003">2020</a>), target gene expression in infected cells relative to uninfected controls were calculated and log2(fold change) was displayed as a heatmap. For singleâ€�cell RNA sequencing analysis from COVIDâ€�19â€�infected patients, scRNAâ€�seq dataset for bronchoalveolar lavage fluid from four healthy controls, three moderate COVIDâ€�19â€�infected patients, and six severe COVIDâ€�19â€�infected patients were downloaded from GEO under the accession number GSE145926 (Liao <i>etÂ al</i>, <a href="#embj2020106057-bib-0018">2020</a>). Analysis was based on the read count matrix, with cell type information provided by meta annotation text file. Reads counts of each gene were collected and calculated using the HDF5 matrix file provided. The read count box plot for HD, moderate, and severe COVIDâ€�19â€�infected patients are drawn based on this analysis.</p> </div> <div class="statisticalanalysis" title="sec"> <div class="title" tagx="title" title="title">
Statistical analysis</div> <p>All data and graphs were analyzed and plotted using Prism 8.0.2 (GraphPad Inc.). Statistical analysis was performed using Student's <i>t</i>â€�test (paired, twoâ€�sided) if not specially stated in the figure legends. Data are presented as the meansÂ Â±Â standard deviation (SD).</p> </div> </div> <div class="data-availability" title="data-availability"> <div class="title" tagx="title" title="title">
Data availability</div> <p>This study includes no data deposited in external repositories.</p> </div> <div class="authorcontributions" title="sec"> <div class="title" tagx="title" title="title">
Author contributions</div> <p>SW designed and performed experiments, analyzed the data, and wrote the manuscript; WL performed experiments, analyzed the data, and wrote the manuscript; HH performed bioinformatics analyses, SKT designed and performed experiments and analyzed the data; QZ performed experiments and analyzed the data; SR and DS provided resources; BAC gave advice in experimental plans and performed experiments; AFC gave advice in experimental plans, performed experiments, and analyzed the data; TMR conceived the overall project and participated in experimental design, data analyses, interpretations, and manuscript writing.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Conflict of interest</div> <p>T.M.R. is a founder of ViRx Pharmaceuticals and has an equity interest in the company. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supporting information</div> <div class="local-data" title="local-data" /> <div class="local-data" title="local-data">  <p>Expanded View Figures PDF</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s001.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> <div class="local-data" title="local-data">  <p>Source Data for Expanded View</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s005.zip">LINK</a> <p>Click here for additional data file.</p>  </div> </div> <div class="local-data" title="local-data">  <p>Review Process File</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s006.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> <div class="local-data" title="local-data">  <p>Source Data for FigureÂ 1</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s002.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> <div class="local-data" title="local-data">  <p>Source Data for FigureÂ 3</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s003.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> <div class="local-data" title="local-data">  <p>Source Data for FigureÂ 4</p>  <div class="media" title="media"><a href="EMBJ-9999-e106057-s004.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>We thank Arun Radhakrishnan and Kristen Johnson from UT Southwestern Medical Center for their advice on ALOD4 purification. We thank members of the Rana laboratory for helpful discussions and advice. The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARSâ€�Related Coronavirus 2, Isolate USAâ€�WA1/2020, NRâ€�52281. This work was supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund to AFC, John and Mary Tu Foundation, and in part by grants from the National Institutes of Health (CA177322, DA039562, DA049524, and AI125103).</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="embj2020106057-bib-0001" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Abrams</span><span class="given-names" tagx="given-names" title="given-names">ME</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Perelman</span><span class="given-names" tagx="given-names" title="given-names">SS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">LS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Endapally</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mar</span><span class="given-names" tagx="given-names" title="given-names">KB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Thompson</span><span class="given-names" tagx="given-names" title="given-names">BM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McDonald</span><span class="given-names" tagx="given-names" title="given-names">JG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schoggins</span><span class="given-names" tagx="given-names" title="given-names">JW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Radhakrishnan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol</span>. <span class="source" tagx="source" title="source">Nat Microbiol</span><span class="volume" tagx="volume" title="volume">5</span>: <span class="fpage" tagx="fpage" title="fpage">929</span>â€"<span class="lpage" tagx="lpage" title="lpage">942</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32284563">32284563</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0002" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Belouzard</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chu</span><span class="given-names" tagx="given-names" title="given-names">VC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Whittaker</span><span class="given-names" tagx="given-names" title="given-names">GR</span></span> (<span class="year" tagx="year" title="year">2009</span>) <span class="mixed-article-title" title="mixed-article-title">Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites</span>. <span class="source" tagx="source" title="source">Proc Natl Acad Sci USA</span><span class="volume" tagx="volume" title="volume">106</span>: <span class="fpage" tagx="fpage" title="fpage">5871</span>â€"<span class="lpage" tagx="lpage" title="lpage">5876</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19321428">19321428</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0003" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Blancoâ€�Melo</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nilssonâ€�Payant</span><span class="given-names" tagx="given-names" title="given-names">BE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">WC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uhl</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hoagland</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Moller</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jordan</span><span class="given-names" tagx="given-names" title="given-names">TX</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Oishi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Panis</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sachs</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Imbalanced Host Response to SARSâ€�CoVâ€�2 Drives Development of COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Cell</span><span class="volume" tagx="volume" title="volume">181</span>: <span class="fpage" tagx="fpage" title="fpage">1036</span>â€"<span class="lpage" tagx="lpage" title="lpage">1045</span>.e9<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32416070">32416070</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0004" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Castiglione</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chiriaco</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Emdin</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Taddei</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vergaro</span><span class="given-names" tagx="given-names" title="given-names">G</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Statin therapy in COVIDâ€�19 infection</span>. <span class="source" tagx="source" title="source">Eur Heart J Cardiovasc Pharmacother</span><span class="volume" tagx="volume" title="volume">6</span>: <span class="fpage" tagx="fpage" title="fpage">258</span>â€"<span class="lpage" tagx="lpage" title="lpage">259</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32347925">32347925</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0005" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chazal</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gerlier</span><span class="given-names" tagx="given-names" title="given-names">D</span></span> (<span class="year" tagx="year" title="year">2003</span>) <span class="mixed-article-title" title="mixed-article-title">Virus entry, assembly, budding, and membrane rafts</span>. <span class="source" tagx="source" title="source">Microbiol Mol Biol Rev</span><span class="volume" tagx="volume" title="volume">67</span>: <span class="fpage" tagx="fpage" title="fpage">226</span>â€"<span class="lpage" tagx="lpage" title="lpage">237</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12794191">12794191</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0006" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">ZL</span></span> (<span class="year" tagx="year" title="year">2019</span>) <span class="mixed-article-title" title="mixed-article-title">Origin and evolution of pathogenic coronaviruses</span>. <span class="source" tagx="source" title="source">Nat Rev Microbiol</span><span class="volume" tagx="volume" title="volume">17</span>: <span class="fpage" tagx="fpage" title="fpage">181</span>â€"<span class="lpage" tagx="lpage" title="lpage">192</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30531947">30531947</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0007" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Daamen</span><span class="given-names" tagx="given-names" title="given-names">AR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bachali</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Owen</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kingsmore</span><span class="given-names" tagx="given-names" title="given-names">KM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hubbard</span><span class="given-names" tagx="given-names" title="given-names">EL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Labonte</span><span class="given-names" tagx="given-names" title="given-names">AC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Robl</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shrotri</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Grammer</span><span class="given-names" tagx="given-names" title="given-names">AC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lipsky</span><span class="given-names" tagx="given-names" title="given-names">PE</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Comprehensive Transcriptomic Analysis of COVIDâ€�19 Blood, Lung, and Airway</span>. <span class="source" tagx="source" title="source">bioRxiv</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.05.28.121889">10.1101/2020.05.28.121889</a></span> [PREPRINT]</span></li> <li tag="ref"><a name="embj2020106057-bib-0008" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Das</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brown</span><span class="given-names" tagx="given-names" title="given-names">MS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">DD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Goldstein</span><span class="given-names" tagx="given-names" title="given-names">JL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Radhakrishnan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span> (<span class="year" tagx="year" title="year">2014</span>) <span class="mixed-article-title" title="mixed-article-title">Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis</span>. <span class="source" tagx="source" title="source">Elife</span><span class="volume" tagx="volume" title="volume">3</span>: <span class="fpage" tagx="fpage" title="fpage">e02882</span></span></li> <li tag="ref"><a name="embj2020106057-bib-0009" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dashtiâ€�Khavidaki</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Khalili</span><span class="given-names" tagx="given-names" title="given-names">H</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Considerations for Statin Therapy in Patients with COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Pharmacotherapy</span><span class="volume" tagx="volume" title="volume">40</span>: <span class="fpage" tagx="fpage" title="fpage">484</span>â€"<span class="lpage" tagx="lpage" title="lpage">486</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32267560">32267560</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0010" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mao</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Superâ€�resolution fluorescenceâ€�assisted diffraction computational tomography reveals the threeâ€�dimensional landscape of the cellular organelle interactome</span>. <span class="source" tagx="source" title="source">Light Sci Appl</span><span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">11</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32025294">32025294</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0011" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pham</span><span class="given-names" tagx="given-names" title="given-names">YH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brown</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span> (<span class="year" tagx="year" title="year">2004</span>) <span class="mixed-article-title" title="mixed-article-title">Effects of 25â€�hydroxycholesterol on cholesterol esterification and sterol regulatory elementâ€�binding protein processing are dissociable: implications for cholesterol movement to theÂ regulatory pool in the endoplasmic reticulum</span>. <span class="source" tagx="source" title="source">J Biol Chem</span><span class="volume" tagx="volume" title="volume">279</span>: <span class="fpage" tagx="fpage" title="fpage">47010â€�6</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15317807">15317807</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0012" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Endapally</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Infante</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Radhakrishnan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span> (<span class="year" tagx="year" title="year">2019</span>) <span class="mixed-article-title" title="mixed-article-title">Monitoring and modulating intracellular cholesterol trafficking using ALOD4, a cholesterolâ€�binding protein</span>. <span class="source" tagx="source" title="source">Methods Mol Biol</span><span class="volume" tagx="volume" title="volume">1949</span>: <span class="fpage" tagx="fpage" title="fpage">153</span>â€"<span class="lpage" tagx="lpage" title="lpage">163</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30790255">30790255</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0013" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fukushi</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mizutani</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Saijo</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Matsuyama</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Miyajima</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Taguchi</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Itamura</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kurane</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Morikawa</span><span class="given-names" tagx="given-names" title="given-names">S</span></span> (<span class="year" tagx="year" title="year">2005</span>) <span class="mixed-article-title" title="mixed-article-title">Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein</span>. <span class="source" tagx="source" title="source">J Gen Virol</span><span class="volume" tagx="volume" title="volume">86</span>: <span class="fpage" tagx="fpage" title="fpage">2269</span>â€"<span class="lpage" tagx="lpage" title="lpage">2274</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16033974">16033974</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0501" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gay</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rye</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Radhakrishnan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span> (<span class="year" tagx="year" title="year">2015</span>) <span class="mixed-article-title" title="mixed-article-title">Switchâ€�like responses of two cholesterol sensors do not require protein oligomerization in membranes</span>. <span class="source" tagx="source" title="source">Biophys J</span><span class="volume" tagx="volume" title="volume">108</span>: <span class="fpage" tagx="fpage" title="fpage">1459</span>â€"<span class="lpage" tagx="lpage" title="lpage">1469</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25809258">25809258</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0014" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hoffmann</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kleineâ€�Weber</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pohlmann</span><span class="given-names" tagx="given-names" title="given-names">S</span></span> (<span class="year" tagx="year" title="year">2020a</span>) <span class="mixed-article-title" title="mixed-article-title">A multibasic cleavage site in the spike protein of SARSâ€�CoVâ€�2 is essential for infection of human lung cells</span>. <span class="source" tagx="source" title="source">Mol Cell</span><span class="volume" tagx="volume" title="volume">78</span>: <span class="fpage" tagx="fpage" title="fpage">779</span>â€"<span class="lpage" tagx="lpage" title="lpage">784</span>.e5<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32362314">32362314</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0015" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hoffmann</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kleineâ€�Weber</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schroeder</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kruger</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Herrler</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Erichsen</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schiergens</span><span class="given-names" tagx="given-names" title="given-names">TS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Herrler</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">NH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nitsche</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020b</span>) <span class="mixed-article-title" title="mixed-article-title">SARSâ€�CoVâ€�2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</span>. <span class="source" tagx="source" title="source">Cell</span><span class="volume" tagx="volume" title="volume">181</span>: <span class="fpage" tagx="fpage" title="fpage">271</span>â€"<span class="lpage" tagx="lpage" title="lpage">280</span>.e8<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32142651">32142651</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0016" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Leibel</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Winquist</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tseu</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shojaie</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nathan</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Snyder</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Post</span><span class="given-names" tagx="given-names" title="given-names">M</span></span> (<span class="year" tagx="year" title="year">2019</span>) <span class="mixed-article-title" title="mixed-article-title">Reversal of surfactant protein B deficiency in patient specific human induced pluripotent stem cell derived lung organoids by gene therapy</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">13450</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31530844">31530844</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0017" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">YQ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aliyari</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">XY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">NN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Watanabe</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">HL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2017</span>) <span class="mixed-article-title" title="mixed-article-title">25â€�hydroxycholesterol protects host against zika virus infection and its associated microcephaly in a mouse model</span>. <span class="source" tagx="source" title="source">Immunity</span><span class="volume" tagx="volume" title="volume">46</span>: <span class="fpage" tagx="fpage" title="fpage">446</span>â€"<span class="lpage" tagx="lpage" title="lpage">456</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28314593">28314593</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0018" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liao</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Singleâ€�cell landscape of bronchoalveolar immune cells in patients with COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Nat Med</span><span class="volume" tagx="volume" title="volume">26</span>: <span class="fpage" tagx="fpage" title="fpage">842</span>â€"<span class="lpage" tagx="lpage" title="lpage">844</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32398875">32398875</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0019" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">SY</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aliyari</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chikere</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Marsden</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">JK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pernet</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nusbaum</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zack</span><span class="given-names" tagx="given-names" title="given-names">JA</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2013</span>) <span class="mixed-article-title" title="mixed-article-title">Interferonâ€�inducible cholesterolâ€�25â€�hydroxylase broadly inhibits viral entry by production of 25â€�hydroxycholesterol</span>. <span class="source" tagx="source" title="source">Immunity</span><span class="volume" tagx="volume" title="volume">38</span>: <span class="fpage" tagx="fpage" title="fpage">92</span>â€"<span class="lpage" tagx="lpage" title="lpage">105</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23273844">23273844</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0020" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lund</span><span class="given-names" tagx="given-names" title="given-names">EG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kerr</span><span class="given-names" tagx="given-names" title="given-names">TA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sakai</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Russell</span><span class="given-names" tagx="given-names" title="given-names">DW</span></span> (<span class="year" tagx="year" title="year">1998</span>) <span class="mixed-article-title" title="mixed-article-title">cDNA cloning of mouse and human cholesterol 25â€�hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism</span>. <span class="source" tagx="source" title="source">J Biol Chem</span><span class="volume" tagx="volume" title="volume">273</span>: <span class="fpage" tagx="fpage" title="fpage">34316</span>â€"<span class="lpage" tagx="lpage" title="lpage">34327</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9852097">9852097</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0021" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mantlo</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bukreyeva</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Maruyama</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Paessler</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Antiviral activities of type I interferons to SARSâ€�CoVâ€�2 infection</span>. <span class="source" tagx="source" title="source">Antiviral Res</span><span class="volume" tagx="volume" title="volume">179</span>: <span class="fpage" tagx="fpage" title="fpage">104811</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32360182">32360182</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0022" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mpeng</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Qin</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">J</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area</span>. <span class="source" tagx="source" title="source">medRxiv</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.04.11.20061473">10.1101/2020.04.11.20061473</a></span> [PREPRINT]</span></li> <li tag="ref"><a name="embj2020106057-bib-0023" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Miller</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dye</span><span class="given-names" tagx="given-names" title="given-names">BR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ferrerâ€�Torres</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hill</span><span class="given-names" tagx="given-names" title="given-names">DR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Overeem</span><span class="given-names" tagx="given-names" title="given-names">AW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shea</span><span class="given-names" tagx="given-names" title="given-names">LD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Spence</span><span class="given-names" tagx="given-names" title="given-names">JR</span></span> (<span class="year" tagx="year" title="year">2019</span>) <span class="mixed-article-title" title="mixed-article-title">Generation of lung organoids from human pluripotent stem cells <i>inÂ vitro</i></span>. <span class="source" tagx="source" title="source">Nat Protoc</span><span class="volume" tagx="volume" title="volume">14</span>: <span class="fpage" tagx="fpage" title="fpage">518</span>â€"<span class="lpage" tagx="lpage" title="lpage">540</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30664680">30664680</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0024" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Osunaâ€�Ramos</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Reyesâ€�Ruiz</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Del Angel</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span> (<span class="year" tagx="year" title="year">2018</span>) <span class="mixed-article-title" title="mixed-article-title">The role of host cholesterol during flavivirus infection</span>. <span class="source" tagx="source" title="source">Front Cell Infect Microbiol</span><span class="volume" tagx="volume" title="volume">8</span>: <span class="fpage" tagx="fpage" title="fpage">388</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30450339">30450339</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0025" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Iwasaki</span><span class="given-names" tagx="given-names" title="given-names">A</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Type I and Type III interferons â€" induction, signaling, evasion, and application to combat COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Cell Host Microbe</span><span class="volume" tagx="volume" title="volume">27</span>: <span class="fpage" tagx="fpage" title="fpage">870</span>â€"<span class="lpage" tagx="lpage" title="lpage">878</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32464097">32464097</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0026" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schneider</span><span class="given-names" tagx="given-names" title="given-names">WM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chevillotte</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rice</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span> (<span class="year" tagx="year" title="year">2014</span>) <span class="mixed-article-title" title="mixed-article-title">Interferonâ€�stimulated genes: a complex web of host defenses</span>. <span class="source" tagx="source" title="source">Annu Rev Immunol</span><span class="volume" tagx="volume" title="volume">32</span>: <span class="fpage" tagx="fpage" title="fpage">513</span>â€"<span class="lpage" tagx="lpage" title="lpage">545</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24555472">24555472</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0027" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">YH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Min</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">JH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">EH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">GE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">MH</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ahn</span><span class="given-names" tagx="given-names" title="given-names">HJ</span></span> (<span class="year" tagx="year" title="year">2017</span>) <span class="mixed-article-title" title="mixed-article-title">The effect of fluvastatin on cardiac fibrosis and angiotensinâ€�converting enzymeâ€�2 expression in glucoseâ€�controlled diabetic rat hearts</span>. <span class="source" tagx="source" title="source">Heart Vessels</span><span class="volume" tagx="volume" title="volume">32</span>: <span class="fpage" tagx="fpage" title="fpage">618</span>â€"<span class="lpage" tagx="lpage" title="lpage">627</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28013371">28013371</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0028" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Spann</span><span class="given-names" tagx="given-names" title="given-names">NJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Glass</span><span class="given-names" tagx="given-names" title="given-names">CK</span></span> (<span class="year" tagx="year" title="year">2013</span>) <span class="mixed-article-title" title="mixed-article-title">Sterols and oxysterols in immune cell function</span>. <span class="source" tagx="source" title="source">Nat Immunol</span><span class="volume" tagx="volume" title="volume">14</span>: <span class="fpage" tagx="fpage" title="fpage">893</span>â€"<span class="lpage" tagx="lpage" title="lpage">900</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23959186">23959186</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0029" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">WT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ji</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhai</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Suchard</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">COVIDâ€�19: epidemiology, evolution, and crossâ€�disciplinary perspectives</span>. <span class="source" tagx="source" title="source">Trends Mol Med</span><span class="volume" tagx="volume" title="volume">26</span>: <span class="fpage" tagx="fpage" title="fpage">483</span>â€"<span class="lpage" tagx="lpage" title="lpage">495</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32359479">32359479</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0030" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tikoo</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kumar</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Karpe</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sanghavi</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Malek</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Srinivasan</span><span class="given-names" tagx="given-names" title="given-names">K</span></span> (<span class="year" tagx="year" title="year">2015</span>) <span class="mixed-article-title" title="mixed-article-title">Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications</span>. <span class="source" tagx="source" title="source">Biochem Pharmacol</span><span class="volume" tagx="volume" title="volume">93</span>: <span class="fpage" tagx="fpage" title="fpage">343</span>â€"<span class="lpage" tagx="lpage" title="lpage">351</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25482567">25482567</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0031" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">de Weerd</span><span class="given-names" tagx="given-names" title="given-names">NA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nguyen</span><span class="given-names" tagx="given-names" title="given-names">T</span></span> (<span class="year" tagx="year" title="year">2012</span>) <span class="mixed-article-title" title="mixed-article-title">The interferons and their receptorsâ€"distribution and regulation</span>. <span class="source" tagx="source" title="source">Immunol Cell Biol</span><span class="volume" tagx="volume" title="volume">90</span>: <span class="fpage" tagx="fpage" title="fpage">483</span>â€"<span class="lpage" tagx="lpage" title="lpage">491</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22410872">22410872</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0032" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Whitt</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span> (<span class="year" tagx="year" title="year">2010</span>) <span class="mixed-article-title" title="mixed-article-title">Generation of VSV pseudotypes using recombinant DeltaGâ€�VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines</span>. <span class="source" tagx="source" title="source">J Virol Methods</span><span class="volume" tagx="volume" title="volume">169</span>: <span class="fpage" tagx="fpage" title="fpage">365</span>â€"<span class="lpage" tagx="lpage" title="lpage">374</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20709108">20709108</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0033" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">ST</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kiessling</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Simmons</span><span class="given-names" tagx="given-names" title="given-names">JA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">White</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tamm</span><span class="given-names" tagx="given-names" title="given-names">LK</span></span> (<span class="year" tagx="year" title="year">2015</span>) <span class="mixed-article-title" title="mixed-article-title">HIV gp41â€�mediated membrane fusion occurs at edges of cholesterolâ€�rich lipid domains</span>. <span class="source" tagx="source" title="source">Nat Chem Biol</span><span class="volume" tagx="volume" title="volume">11</span>: <span class="fpage" tagx="fpage" title="fpage">424</span>â€"<span class="lpage" tagx="lpage" title="lpage">431</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25915200">25915200</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0034" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">ST</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kreutzberger</span><span class="given-names" tagx="given-names" title="given-names">AJB</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kiessling</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tamm</span><span class="given-names" tagx="given-names" title="given-names">LK</span></span> (<span class="year" tagx="year" title="year">2016</span>) <span class="mixed-article-title" title="mixed-article-title">The role of cholesterol in membrane fusion</span>. <span class="source" tagx="source" title="source">Chem Phys Lipids</span><span class="volume" tagx="volume" title="volume">199</span>: <span class="fpage" tagx="fpage" title="fpage">136</span>â€"<span class="lpage" tagx="lpage" title="lpage">143</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27179407">27179407</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0035" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zang</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gomez Castro</span><span class="given-names" tagx="given-names" title="given-names">MF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McCune</span><span class="given-names" tagx="given-names" title="given-names">BT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rothlauf</span><span class="given-names" tagx="given-names" title="given-names">PW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sonnek</span><span class="given-names" tagx="given-names" title="given-names">NM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brulois</span><span class="given-names" tagx="given-names" title="given-names">KF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Greenberg</span><span class="given-names" tagx="given-names" title="given-names">HB</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">TMPRSS2 and TMPRSS4 promote SARSâ€�CoVâ€�2 infection of human small intestinal enterocytes</span>. <span class="source" tagx="source" title="source">Sci Immunol</span><span class="volume" tagx="volume" title="volume">5</span>: <span class="fpage" tagx="fpage" title="fpage">eabc3582</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32404436">32404436</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0036" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">XJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Qin</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">YC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lei</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">L</span></span><i>etÂ al</i> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Inâ€�hospital use of statins is associated with a reduced risk of mortality among individuals with COVIDâ€�19</span>. <span class="source" tagx="source" title="source">Cell Metab</span><span class="volume" tagx="volume" title="volume">32</span>: <span class="fpage" tagx="fpage" title="fpage">176</span>â€"<span class="lpage" tagx="lpage" title="lpage">187</span>.e4<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32592657">32592657</a></span></span></li> <li tag="ref"><a name="embj2020106057-bib-0037" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">Xâ€�S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Zâ€�H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shannon</span><span class="given-names" tagx="given-names" title="given-names">CP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tebbutt</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kollmann</span><span class="given-names" tagx="given-names" title="given-names">TR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fish</span><span class="given-names" tagx="given-names" title="given-names">EN</span></span> (<span class="year" tagx="year" title="year">2020</span>) <span class="mixed-article-title" title="mixed-article-title">Interferonâ€�a2b treatment for COVIDâ€�19</span>. <span class="source" tagx="source" title="source">medRxiv</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.04.06.20042580">10.1101/2020.04.06.20042580</a></span> [PREPRINT]</span></li> </ul> </div> </div>  </body></html>